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Abstract: In Escherichia coli, penicillin-binding protein 3 (PBP3), also known as FtsI, is a central
component of the divisome, catalyzing cross-linking of the cell wall peptidoglycan
during cell division. PBP3 is mainly periplasmic, with a 23 residues cytoplasmic tail and
a single transmembrane helix. We have solved the crystal structure of a soluble form of
PBP3 (PBP357-577) at 2.5 Å revealing the two modules of high molecular weight class
B PBPs, a carboxy terminal module exhibiting transpeptidase activity and an amino
terminal module of unknown function. To gain additional insight, the PBP3 Val88-
Ser165 subdomain (PBP388-165), for which the electron density is poorly defined in
the PBP3 crystal, was produced and its structure solved by SAD phasing at 2.1 Å. The
structure shows a three dimensional domain swapping with a β-strand of one molecule
inserted between two strands of the paired molecule, suggesting a possible role in
PBP357-577 dimerization.
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Response to Reviewers: Dear Editors,
Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation
We have tried to address the concerns of reviewer 1 about the structure. Typographical
errors found mainly by reviewer 2 have been corrected and the paper was read by an
English native speaker. Finally, as suggested by reviewer 3, we have expanded the
description of the structure and modified the figures accordingly. Details follow.
Reviewer #1
1.lines 125-129 … The authors state that PBP3(57-577) crystalization “could not be
reproduced despite countless attempts.” First, surely there were not “countless”
attempts. About how many attempts were made, and do the authors have any ideas
about what the problem might be? This is rather important since it is unlikely that the
work can be replicated by others if it cannot be replicated here. Second, with only one
successful crystallization, how confident are the authors about the nature of the
results?
R: The apparent very narrow range of crystallization conditions resulted in only some
very small badly diffracting crystals and one crystal diffracting at 2.5 Å. This sentence
was added to the manuscript.
In the case of several PBPs structures, the difficulties encountered in obtaining high
resolution x-ray data sets, in reproducing crystals or even obtaining crystals, are mainly
due to their nature of multi-domain proteins, for which several relative conformations of
the different domains co-exist in solution. That’s why multi-domain protein structures
are frequently determined from a single X-ray dataset but this has no impact on the
soundness of structure determination.
2. lines 212-213 … The PBP3 structure was evidently not determined de novo, but by
comparison with the structure of PBP2 from a different organism, N. gonorrhoeae.
This, when combined with the fact that only one crystallization attempt was successful,
makes me wonder if this is the real structure of PBP3 or if it is only a single possible
structure that can be made to conform to the structure of a somewhat distant
homologue. Why can the structure not be generated on its own, and what are the
limitations imposed by the modeling method?
R: Structure determination by molecular replacement using the structure of a
homologous protein (NgPBP2) is also a standard method that does not impact the
confidence that the structure determined corresponds to the protein that has been
crystallized. R and Rfree values are good criteria to ensure that the structure
corresponds to the X-ray measures, independently of the initial structure used for
molecular replacement.
Efforts have been made to clearly show in figure 1 the part of the structure that was
determined from X-ray data and the modeled parts of the structure.
3. lines 378-380 … The authors could not reproduce interactions between the
PBP3(88-165) fragment and other cell division proteins. If these interactions do not
occur, doesn’t this call into question the biological relevance of the structure obtained
for this fragment?
R: No. The structure of the domain 88-165 compares well with the equivalent domains
of other class B-PBPs. The biological relevance of the swapping associated with the
structure of the domain alone is indeed questionable but we think that the discussion
states it clearly.
4. In Figure S3, very little of the PBP3(57-577) seems to have co-precipitated with the
peptidoglycan preparation. Why? The authors should quantify how much was
precipitated and compare it to what might be expected.
R: A similar test was done with LpoA-LpoB (Typas et al, Cell. 2010, 143:1097) without
quantification, which is difficult. Clearly, only a fraction of the protein was precipitated.
A possible explanation is that PBP3 interacts only with the septal peptidoglycan, which
represents only a small proportion of the total peptidoglycan.
Minor comments
5. line 69 … should be “LpoB” (capital “B”)
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Done
6. line 256 … should be “PBP-structures” (plural)
OK
Reviewer #2
1.There are many typos and errors in comma usage and grammar that should be
corrected.
Minor points:
1. l. 47: it is not clear what is meant by "direct" peptidoglycan synthesis. Is there
something like indirect synthesis?
“Direct” has been removed
2. l. 69: should be "LpoB" with capital "B"
Done
3. l. 96: the 2XYT medium should be defined.
Done
4. l. 98: should be "0.5 mM"
Done
5. l. 113/117/119: what is meant with "ch/h" and "cm/h". Flow rates should be given in
"ml/min" or "ml/h".
R: Typing error, ch/h doesn’t exist,  it’s cm/h (linear flow rate, which is independent of
the diameter of the column, instead of the flow rate in ml/h  which is dependent of the
column diameter). The linear flow rate is preferred by people making a scale-up
because it’s the real value independent of the column size allowing to compare
different size of columns; for example 100 mL/h used for two columns having a surface
doubling will make a factor two for the residence time.
Linear flow rate (cm/h) X surface (cm2) = volumetric flow rate (ml/h)
In our case with the XK50 column (diameter = 5 cm surface = 19.63 cm2
31 cm/h = 608 mL/h; 15 cm/h = 294 mL/h
6. l. 122: it is not clear what is meant by "three-dimensional environment with 30% of
alpha-helix". Please re-phrase to make the sentence clear.
R: The sentence was changed.
7. l. 127: "CAPS" needs to be defined.
Done
8. l. 197-202. "KDa" should be corrected to "kDa".
Done; also in figure legends.
9. l. 213: missing blank.
Added
10. l. 229: define "mDAP"
Done
11. l. 264-264: What is meant by "...and the conformation of the segment 402-420 are
conserved in all PBPs."? What is meant here with "conformation"? Also, you need to
clarify if the "conformation" is conserved in all known PBP structures, or in all class B
PBPs, or what is meant here.
R: The sentence was modified
12. l. 284. Here, it does not become clear why the comparison with other PBPs
provides evidence for flexible junction between the modules. What is the evidence, and
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how has it been obtained? Also, have other computational methods been used to
assess the flexibility?
R: Evidence is suggested also by apo and acyl structures of PBP3 from Pseudomonas
aeruginosa (Sainsbury, JMB, 405, 173-184). The flexibility of the junction also exists in
class A PBPs. We have modified the sentence, added a figure as suggested by
reviewer 3 remark 9, and added references.
13. l. 287: what is meant with "processive displacement of the divisome"?
R: It means divisome displacement during processive glycan chain synthesis. The
sentence has been simplified
14. l. 298: should be "Marrec-Farley" with capitol "F".
OK (Marrec-Fairley)
15. l. 425. It must be clearly stated in the heading of the legend and in part (a) that the
figure shows a model of the PBP3 structure, and not the crystal structure itself (as is
written).
R: The figure was modified according to reviewer3’s suggestion showing now the
crystal structure in cartoon and a light trace of the modelled loops.
16. l. 431. should be "Tyr".
OK
17. Figure 1: should it be "Loop 202-228" (instead of "Loop 220-228") to be consistent
with the text?
R: The correction was done in figure 1
Reviewer #3:
1. Analysis of Figure 1 gives the reader the impression that the structure includes the
transmembrane region, as well as the full N-terminal domain. Reading of the figure
legend, however, indicates that the TM was modeled, and so were all of the regions in
cyan. Since this is a very important figure for the paper, and could be eventually used
by other scientists for teaching, etc, it should only include the regions that could be
traced in a trustworthy fashion in the map. The TM region does not have to be included
(it is not helpful for the figure, or even mentioned in the text), and all loops and regions
that were modeled should be replaced by dots.
R: The figure has been modified as suggested by the reviewer. The modeled loops are
now shown in very light grey and the TM helix has been removed. We have also
followed the reviewer’s remark 15 suggesting showing beta-strands colored differently
from alpha-helices.
2. It is unclear to the reader why authors started their clone at residue 57; a schematic
figure could be included, describing the exact construct that was used and the
structure that was traced.
R: The construct starting at residue 57 was less prone to degradation that a construct
starting at residue 37. See Fraipont C et al. (1994) Engineering and overexpression of
periplasmic forms of the penicillin-binding protein 3 of Escherichia coli. Biochem J 298 (
Pt 1): 189-195. The reference has been added in the material and method section.
Figure 1 now clearly shows the construct and the difference between what was seen in
the map and the modeled loops.
3. P. 10, lines 220-221, it is rather strange to mention that the C-terminus is associated
to the N-terminus; do authors mean to say that it interacts closely?
R: The sentence has been made clearer.
4. Although one has the impression that there are 4 individual figures, in fact they are
only 2, parts A and B of the same figure having been separated into different files. As a
consequence, this manuscript only has 2 figures. Authors could illustrate their
manuscript better by adding additional figures; for example, showing the ‘long groove’
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that is alluded to on p. 10, lines 227-228.
R: We have added some figures: a model with part of the substrate showing the long
groove (remark 5) and a figure showing the superposition of different class B-PBPs
(remark 9). We have included the supplementary figures in the manuscript.
Figure 1: structure of PBP3
Figure 2: Active site
Figure 3: Junction
Figure 4: Domain 88-165
Figure 5 : PBP3 oligomerization
Figure 6 : Interaction with peptidoglycan
5. There is a paper from the Mobashery lab describing the structure of an E. coli PBP
(5/6) with a peptide in the active site; since authors mention that their long groove
could bind substrate, how does it compare to this paper? Is it possible to model a
peptide in their structure?
R: We have modeled the acyl-enzyme with D-Glu-mDap-D-Ala linked to the active
serine and made a figure of it. The model is based on an unpublished acyl-enzyme
structure that we have obtained with another PBP (the DD-peptidase from
Actinomadura R39) rather than the Mobashery’s one, which has a lysine instead of
diaminopimelic acid in the peptide
6. P.10, after lines 223-224, a reference should be cited.
R: As lines 223-224 are empty, we believe that reviewer’s remark relates to lines 233-
234, where we have added a reference.
7. P.12, this part of the text refers to figure 1b, which is rather problematic. Details
about a pocket are described, but by looking at the figure one does not have the
impression to see a pocket; since one of the beta-strands was shown as sticks (which
is not really helpful), it gives the reader the impression that there is a peptide bound to
the active site. In order to make this clearer, authors should show the active site with
arrows for beta strands (that should be labeled as per other PBPs … the beta-strands
neighboring the active site on this figure are beta3 and beta4).
R: There are now two figures showing the active site. The first (figure 2a) shows the
groove (cf remark 5) and the second is the former figure 1b (now 2b) modified as
suggested by the reviewer (strand beta3 shown as a strand and labeled). Both are in
stereo (cf remark 13)
8. P.12, lines 269-270: please mention the nomenclature for the beta strands involved,
and add references here.
R: Nomenclature and references have been added
9. P.12, lines 283-284: these interesting sentences could be illustrated by a figure
highlighting the differences between junctions for different PBPs (and references
should also be added)
R: Details were added to the text and a new figure illustrates these sentences (figure
3).
10. 9. P. 14, line 310, please replace ‘tridimensional’ by ‘three-dimensional’
Done
11. If authors only have 2 figures in their manuscript, why did they include three
supplementary figures? All of the data can be included in the main text.
We have integrated all the figures in the manuscript
12. It is curious that on p. 16 lines 374-375 authors discuss the fact that a role for
domain swapping in the in vivo dimerization process of PBP3 is elusive, and in lines
380-381 go on to discuss that their could be a role for this in vivo.
R: In lines 380-381, we mention the possible influence of the in vitro dimerization of
domain 88-165 on the result of interaction tests. We have slightly modified the
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sentence to avoid confusion
13. Figure 1, legend: this reviewer recommends that secondary strand elements be
labeled, as suggested above. What do authors mean by ‘unhide’ Tyr514? If their
objective is to show it clearly, they could potentially change the angle, or make a stereo
figure, or make a LigPlot figure ...
R: See remark 7
14. I’m not quite sure how relevant Fig. 2b is, especially considering that authors
clearly mention that these interactions are probably not relevant in the full-length PBP3
structure. They could potentially replace it by supplementary data, or other images of
the full-length crystal structure. What does a surface charge diagram look like?
R: We have kept this illustration, which makes the description of the swapping easier to
understand.
15. These authors published a beautiful review article in FEMS a few years ago where
they showed the transpeptidase domain of PBPs with beta-strands colored differently
from alpha-helices; they could perhaps adopt that strategy for this paper, and modify
Figs. 1a/1b accordingly.
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Abstract 26 
In Escherichia coli, penicillin-binding protein 3 (PBP3), also known as FtsI, is a central 27 
component of the divisome, catalyzing cross-linking of the cell wall peptidoglycan during cell 28 
division. PBP3 is mainly periplasmic, with a 23 residues cytoplasmic tail and a single 29 
transmembrane helix. We have solved the crystal structure of a soluble form of PBP3 30 
(PBP357-577) at 2.5 Å revealing the two modules of high molecular weight class B PBPs, a 31 
carboxy terminal module exhibiting transpeptidase activity and an amino terminal module of 32 
unknown function. To gain additional insight, the PBP3 Val88-Ser165 subdomain (PBP388-33 
165), for which the electron density is poorly defined in the PBP3 crystal, was produced and its 34 
structure solved by SAD phasing at 2.1 Å. The structure shows a three dimensional domain 35 
swapping with a β-strand of one molecule inserted between two strands of the paired 36 
molecule, suggesting a possible role in PBP357-577 dimerization.  37 
  38 
  39 
 3 
Introduction 40 
The penicillin-binding proteins (PBPs) synthesize and remodel the cell wall peptidoglycan, a 41 
major component of the bacterial cell wall that gives the cell its shape and rigidity [1-4]. They 42 
are found in all bacteria and represent major targets in anti-biotherapy, especially for the 43 
widely used -lactam antibiotics. Penicillin-binding proteins belong to the family of acyl-44 
serine transferases and are traditionally separated into high-molecular-weight  (HMW) PBPs 45 
and low-molecular-weight (LMW) PBPs based on molecular weight and sequence homology 46 
[4-6]. The former enzymes act as transpeptidases in vivo and are involved in peptidoglycan 47 
synthesis while the latter are carboxypeptidases and endopeptidases [7] thought to remodel 48 
peptidoglycan during the bacterial life cycle but details of their in vivo activities are not well 49 
established. The HMW-PBPs group can be subdivided into classes A and B, the LMW group 50 
into classes A, B and C. Class B HMW-PBPs can be further divided into subclasses and 51 
Escherichia coli PBP3 is paradigmatic of subclass B3 that groups class B PBPs from Gram 52 
negative bacteria involved in cell division. Some PBPs from Gram positive bacteria involved 53 
in spore peptidoglycan synthesis also belong to subclass B3, e.g. SpoVD from Bacillus 54 
subtilis. 55 
During cell division, the peptidoglycan is synthesized by the periplasmic part of a 56 
macromolecular complex called the divisome, made up of at least 20 proteins in Escherichia 57 
coli [8]. Cell division is initiated by the polymerization of tubulin homolog FtsZ into a 58 
contractile ring at midcell [9] and the other division proteins are recruited sequentially to the 59 
septal ring. FtsZ first associates with FtsA, ZapA and ZipA that stabilize the FtsZ filaments 60 
and tether them to the cytoplasmic membrane. The divisome then matures with a long delay 61 
between formation of the Z ring and recruitment of the proteins downstream of FtsK[10]. 62 
These proteins involved in septal peptidoglycan synthesis are now thought to be recruited as 63 
subcomplexes, at least FtsQ/L/B [11] and FtsW/PBP3 [12]. FtsN, which contains a SPOR 64 
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peptidoglycan binding domain, is the last essential division protein that localizes at the 65 
septum [13]. Finally, various proteins not essential for septal peptidoglycan synthesis 66 
associate with the divisome: the Tol/Pal complex involved in the invagination of the outer 67 
membrane [14], and the peptidoglycan hydrolase AmiC (and its activator NlpD) that plays an 68 
essential role in the separation of daughter cells [15]. Recently, the outer membrane protein 69 
LpoB was also shown to associate with the divisome and to regulate peptidoglycan synthesis 70 
by interacting with the glycan chain polymerase/transpeptidase PBP1b [16]. 71 
In E. coli, PBP3 (FtsI) is an essential protein of the divisome, catalyzing peptide cross-bridges 72 
between the glycan chains of the peptidoglycan. PBP3 is involved in many interactions within 73 
the divisome. It interacts directly with PBP1b which localizes at the division site during 74 
septation in a PBP3 dependent fashion [17]. PBP3 works in concert with PBP1b to 75 
incorporate the nascent glycan chain into the existing peptidoglycan [4]. The N-terminal 56 76 
residues of PBP3 (containing a cytoplasmic peptide, the transmembrane segment and a short 77 
periplasmic peptide) interact with PBP1b in a two-hybrid assay. However other interacting 78 
sites should be present in the periplasmic part of PBP1b and PBP3 [17]. PBP3 also interacts 79 
directly with FtsW and with FtsN, which itself interacts with PBP1b and stimulates its activity 80 
[18]. These proteins are able to form a discrete complex independently of the other cell 81 
division proteins [12]. Interaction of PBP3 with FtsA, FtsK, FtsQ [19] or FtsL [20] were also 82 
reported but the structural details and the sites of interaction between PBP3 and the proteins 83 
of the divisome remain to be elucidated.  84 
The ftsI gene encodes a 588 residues protein but proteolytic cleavage removes 11 amino acids 85 
at the C-terminal part of the protein[21]. We have solved the crystal structure of the 86 
periplasmic domain of PBP3 (residues 57-577) at 2.5 Å. We have also produced, purified, 87 
crystallized and solved the structure of the Val88-Ser165 subdomain (PBP388-165), a potential 88 
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protein-protein interaction domain, which was poorly defined in the electron density map of 89 
PBP357-577.  90 
 91 
 92 
Material and Methods 93 
Bacterial strains, oligonucleotides and media: Bacterial strains were E. coli Top 10F’ for 94 
cloning (Invitrogen, USA) and E. coli C41(DE3) for expression [22]. Oligonucleotides were 95 
from Eurogentec. The rich media used were 2XYT (bacto-tryptone 16 g, yeast extract 10 g, 96 
NaCl 5 g, water 1 l, pH 7.0.) or Luria-Bertani (LB) medium supplemented with ampicillin 97 
(100 µg ml
-1
), chloramphenicol (20 or 30 µg ml
-1
), kanamycin (50 µg ml
-1)
 and IPTG (0.5 98 
mM) when appropriate.  99 
 100 
PBP357-577: Production, purification, crystallization, data collection and structure 101 
refinement. 102 
Plasmids used were pDML232 for the PBP3 and pDML237 for SecB[23]. Fermentation of E. 103 
coli  strain W3110M  was performed in RFB MIL11/03 at 37°C to overexpress the PBP3(57-104 
577), allowing to obtain soluble protein expression at 210 mg/l of culture. 105 
50 g of wet bacterial pellet corresponding to 1 litre of culture were suspended into 150 ml of 106 
100 mM Tris (pH 8), 0.1 mM PMSF buffer, under magnetic stirring in an ice batch for 30 107 
minutes. Mechanical lysis of bacteria was performed with a Rannie at 650 bars and cooling. 108 
Cell lysate was centrifuged on a JOUAN SR 20.22 at 42 000 g for 1 hour at 4°C. We then 109 
centrifuged the supernatant on a Beckman XL90 at 100 000 g for 30 minutes at 4°C, in order 110 
to clarify the solution.  111 
The clarified supernatant was loaded on a S-Sepharose Fast Flow column (XK50/30) 112 
equilibrated with buffer A (100 mM Tris (pH 8), 10% glycerol, 10% ethylene glycol) at 608 113 
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ml/h. Elution was performed with a linear gradient from 100% of buffer A to 40% of buffer B 114 
(buffer A + 1 M Nacl). PBP3 was eluted at about 20% of buffer B. Eluate was diluted 1/3 in 115 
buffer A and loaded on an S-Sepharose Hiload (XK16/10) column equilibrated in buffer A at 116 
588 ml/h. Elution was performed with buffer C (100 mM Tris (pH 8), 10% glycerol, 10% 117 
ethylene glycol, 0.5 M NaCl).  The eluate collected in one column volume was then purified 118 
on a Superdex 200 (XK50/60) column at 294 ml/h to obtain a highly purified and 119 
homogenous protein. 120 mg of purified protein were obtained at 1.6 mg/ml (UV 120 
measurement). N-terminal sequence was checked and confirmed. Circular dichroism analyses 121 
showed that the protein has a stable three-dimensional structure with 30% of alpha-helix. The 122 
FRET (resonance energy transfer) measurements showed a rotational coefficient of 38 ns 123 
which demonstrated the monodisperse status of the population with an apparent molecular 124 
weight of 53 KDa.  125 
Crystals of PBP357-577 were grown at 20°C by hanging drop vapor diffusion. Crystals were 126 
obtained by mixing 5 µl of a 18 mg/ml protein solution (also containing 0.5 M NaCl and 20 127 
mM Tris, pH 8), 4 µl of well solution (2.5 M ammonium sulfate and 0.1 M N-cyclohexyl-3-128 
aminopropanesulfonic acid (CAPS), pH 10), and 1 µl of 0.1 M NaCl solution. Crystals 129 
appeared after several months and the apparent very narrow range of crystallization 130 
conditions resulted in only some very small badly diffracting crystals and one crystal 131 
diffracting at 2.5 Å. Diffraction data were measured on Beamline ID29 at the European 132 
Synchrotron Radiation Facility (ESRF, Grenoble, France) and processed using Mosflm [24] 133 
and SCALA from the CCP4 program suite. [25] The structure of PBP3 was solved by 134 
molecular replacement with the program PHASER [26] using the structure of PBP2 from 135 
Neisseria gonorrhoeae (PDB id: 3equ) as the initial search model. Refinement was carried out 136 
using REFMAC5, [27] TLS, [28] and Coot. [29]. The final refinement statistics are given in 137 
Table 1.  138 
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 139 
PBP388-165: Production, purification, crystallization, data collection and structure 140 
refinement. 141 
The ftsI fragment encoding PBP388-165 was amplified by PCR using plasmid pMVRI [17] as 142 
template and oligonucleotides  5’-GGACCCGGGGTAAAAGCGATTTGGGCTGACCC-3’ 143 
and 5’-GCCGGATCCTTAAGAC TCTTCACGCAGATGAATCCC-3’ as primers (XmaI and 144 
BamHI are underlined). The PCR fragment was cloned into the pJet1.2/blunt cloning vector 145 
(Fermentas), sequenced, digested with XmaI and BamHI and inserted into the same sites of 146 
plasmid pET-52b(+). The resulting plasmid pDML2042 codes for the PBP388-165 with an N-147 
terminal strep-tag. The strep-tag- PBP388-165 was isolated from E. coli C41(DE3) harbouring 148 
pDML2042 grown at 37° C in 2XYT medium  in the presence of 0.5 mM IPTG for 3h. The 149 
harvested cells were suspended in 40 ml of 100 mM Tris-HCl pH 8.0, 150 mM NaCl, 1mM 150 
EDTA containing a protease inhibitor cocktail (Roche) (buffer C), broken 5 times into a high-151 
pressure homogenizer (Emulsiflex-C3 Avestin Inc.) and centrifuged at 25000g for 40 min. 152 
The supernatant was filtered (0.45µ) and applied to a 5 ml Strep-Tactin IBA column. After 5 153 
washes with buffer C, the strep-tag-PBP388-165 was eluted in 100 mM Tris-HCl pH8.0, 150 154 
mM NaCl, 1mM EDTA, 2.5mM desthiobiotin. The fractions of interest (5ml) were dialyzed 155 
against 2 L of buffer C with a 3,500 Dalton cut off membrane and analyzed by SDS-18% 156 
PAGE. About 6 mg of PBP388-165 per liter of culture were produced and purified to 90% 157 
purity. The strep-tag was removed from PBP388-165 before crystallization. 158 
Crystals of PBP388-165 were grown at 20°C by hanging drop vapor diffusion. Crystals were 159 
obtained by mixing 4 µl of a 7.5 mg/ml protein solution containing 0.15 M NaCl and 0.1 M 160 
Tris, pH 8 1mM EDTA, and 1 µl of well solution (2 M ammonium sulfate and 0.1 M citrate, 161 
pH 3.5). The structure of PBP388-165 was solved by single anomalous diffraction using a 162 
selenomethionine substituted SePBP388-165 crystal. Selenomethionine substituted SePBP388-165 163 
 8 
was expressed by using minimal medium supplemented with selenomethionine and purified 164 
and crystallized as PBP388-165. Diffraction data for the SePBP388-165 crystals were measured on 165 
Beamline PROXIMA 1 at SOLEIL (Paris, France). Data were processed using XDS [30] and 166 
initial structure determination of SePBP388-165 was determined with the help of SHELXC/D/E 167 
[31], Parrott [32] and Buccaneer [33].  168 
Refinement was carried out on native PBP388-165 using REFMAC5, [27] TLS, [28] and Coot. 169 
[29]. Diffraction data for the native PBP388-165 were measured on Beamline BM30A at the 170 
European Synchrotron Radiation Facility (ESRF, Grenoble, France) and processed using 171 
Mosflm [24] and SCALA from the CCP4 program suite. [25] Data and final refinement 172 
statistics are given in Table 1.  173 
 174 
Western blotting: Western blotting was carried out as described [12]. PBP3, PBP1b and 175 
FtsN were revealed with respective polyclonal antibodies and FtsW was probed with 176 
monoclonal anti-HA-Peroxydase (HighAffinity (3F10) Roche). 177 
.  178 
Light Scattering (DLS and SLS).  179 
Dynamic and static light scattering data were recorded on a DynaPro NanoStar instrument 180 
(Wyatt Technology Corporation) operated in batch mode at 20°C and fitted with a laser beam 181 
emitting at 658 nm with power auto-attenuation. Scattering angles were 90° for both DLS 182 
(avalanche photodiode) and SLS (silicon PIN photodetector). Measurements were performed 183 
under buffer conditions and concentration used for crystallogenesis. Samples were filtered on 184 
Whatman Anotop 10 inorganic membrane (0.02 µm cut off) and loaded into a 10 µl quartz 185 
microcuvette. Data were averaged from 20 acquisitions of the scattered light intensity during 186 
5 s, with a sum of squares error value below 100. Scattering data were analyzed using 187 
DYNAMICS v. 7.1.1.3 software (Wyatt Technology Corp.) that includes the DYNALS 188 
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module for distribution analysis in photon correlation spectroscopy. A globular protein model 189 
was used for mass estimation in DLS and a dn/dc value of 0.185 ml/g for mass calculations in 190 
SLS. Theoretical protein hydrodynamic radii were calculated from pdb files with program 191 
HYDROPRO [34].  192 
 193 
Protein binding to peptidoglycan. Protein binding to peptidoglycan was performed as 194 
described in Typas et al. [16]. Briefly, 10 µg of protein were incubated with a peptidoglycan 195 
suspension of E. coli MC1061. The peptidoglycan was pelleted, washed and resuspended in 196 
2% SDS. The unbound fraction, the wash fraction and the resuspended pellet were analysed 197 
by SDS-18% PAGE. A control sample was realized without peptidoglycan.  198 
 199 
Gel filtration. Gel filtration experiments were performed on a Superdex 200 10/300 GL and 200 
on a Superdex 75 10/300 GL for PBP357-577 and PBP388-165 respectively. The proteins were 201 
used at the same concentration and in the same buffer as in the crystallogenesis assay and in 202 
DLS. 200 µl of protein were injected. Standard proteins (lysozyme 14.3 kDa, trypsin inhibitor 203 
20.1 kDa, carbonic anhydrase 31 kDa, bovine serum albumin 66.5 kDa) were used for 204 
calibration.   205 
 206 
Accession numbers. The atomic coordinates for the crystal structure of PBP357-577 and 207 
PBP388-165 are available at the Protein Data Bank with the accession numbers PDB ID: 4BJP 208 
and 4BJQ.  209 
Results and discussion 210 
Structure determination 211 
The crystal structure of a soluble form of PBP3, including residues 57 to 577, was solved at 212 
2.5 Å resolution. The structure of PBP3 was solved by molecular replacement using the 213 
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structure of PBP2 from N. gonorrhoeae (PDB id: 3equ) [35]. PBP3 crystallizes in space group 214 
P6122 with one molecule in the asymmetric unit. The structure was built from residues 71 to 215 
567 but absence of detectable electronic density did not allow structure determination for 216 
residues 93-112, 119-141, 152-162, 202-228 and 537-543. PBP3 structural information was 217 
supplemented by independently solving the Val88-Ser165 subdomain structure (see below). 218 
Final Rcryst and Rfree values for the PBP3 structure determination are 19.9 % and 24.5 % 219 
respectively.  220 
The overall fold of periplasmic PBP3 is bimodular (Fig. 1). The C-terminal module is 221 
responsible for the transpeptidase activity but no clear function has been assigned yet to the 222 
N-terminal module of the construct. 223 
 224 
Transpeptidase module and active site 225 
The C-terminal module shares its overall fold with the transpeptidase domain found in all 226 
PBPs [5,36]. Structure-based alignments of the PBP3 transpeptidase domain show little 227 
structural deviations from the corresponding domains of class B3 PBPs with r.m.s.deviations 228 
of 1.3 Å (Acitenobacter baumanii PBP3 [37]), 1.3 Å (Pseudomonas aeruginosa PBP3 [38] 229 
and 1.4 Å (N.gonorrhoeae PBP2 [35] and larger deviations for class B PBPs from other 230 
subgroups (1.7 Å, 2.1 Å,  2.1 Å, and 2.1 Å for Mycobacterium tuberculosis PBPA [39], 231 
Streptococcus pneumoniae PBP2x [40], S. pneumoniae PBP2b [41] and Staphylococcus 232 
aureus PBP2a [42], respectively). The active site responsible for the transpeptidase activity of 233 
PBP3 is located in a long groove that can accommodate the carboxy-terminal residues of the 234 
PBP3 natural substrate, the peptidoglycan stem pentapeptide L-Ala-γ-D-Glu-meso-235 
diaminopimelic acid (mDAP)-D-Ala-D-Ala (Fig 2a). 236 
The transpeptidase activity of PBP3 relies on eight residues, Ser307, Lys310, Ser359, 237 
Asn361, Lys494, Thr495, Gly496 and Thr497, found with few exceptions in all penicillin-238 
binding enzymes (Fig. 2b).  These residues form three conserved sequence motifs (Ser-Xaa-239 
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Xaa-Lys, Ser-Xaa-Asn and Lys-Thr-Gly-Thr) and are also responsible for the binding of β-240 
lactam antibiotics to the active site of PBPs [5].  241 
The mechanism leading to linkage between the stem peptides of two glycan chains involves 242 
an acyl-enzyme formed between the active serine and the penultimate D-Ala of one stem 243 
peptide, releasing the ultimate D-Ala. In this mechanism, the nucleophylicity of the active 244 
serine Ser307 would be enhanced by Lys310, and Ser359 would be important for back-245 
donation of the proton to the active serine during the acylation step. Deacylation involves the 246 
attack of the acyl bond by the free amine group of a second stem peptide diaminopimelic acid. 247 
Lys494 could play an important role in deacylation in concert with Ser359, as suggested for 248 
other PBPs [43-45]. 249 
Asn361 should be important for proper positioning of the interpeptidic amide group linking 250 
the penultimate D-Ala to the diaminopimelic acid residue. Substitution of Asn361 by a serine 251 
causes a dramatic change in pole shape [46]. The pointed polar caps observed in the E. coli 252 
mutant harboring this mutation appeared to be associated with the activity of PBP3. Asn361 253 
differentiates PBP3 from its elongation homologue PBP2. The presence of an aspartic acid at 254 
this position in E. coli PBP2 and more generally in all PBPs of class B2( which contains 255 
Gram negative class B PBPs associated to elongation) is a noticeable exception to the 256 
conservation of this residue in peptidoglycan synthesizing PBPs. The nature of the amino-acid 257 
should be of importance for the fine structural conformation of peptidoglycan. 258 
Finally, both threonine residues of the Lys-Thr-Gly-Thr motif should serve as an anchor to the 259 
C-terminal carboxylate group of the pentapeptide. They are found hydrogen bonded to the 260 
penultimate D-Ala carboxylate in structures of DD-peptidases in complex with peptide 261 
fragments [45,47]. 262 
In all ligand-free PBP-structures a water molecule is observed in the oxyanion hole. In PBP3, 263 
the oxyanion hole, defined by the amine groups of residues 307 and 497, is unexpectedly 264 
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occupied by the hydroxyl group of Tyr514 that is at 2.7 Å from Ser307N and 3.25 Å from 265 
Thr497N (Fig. 2b). Sequence alignment shows that Tyr514 is unique to PBP3 among class B 266 
PBPs. The side chain of Tyr514 is free to easily rotate and liberate the oxyanion hole and 267 
should not play a particular role in transpeptidation. 268 
The rear side of the PBP3 active site is made of residues Phe417-Gly-Tyr-Gly (Fig. 2b). The 269 
motif Tyr/Phe/Ile-Gly-Tyr/Gln-Gly and the tertiary structure of the segment 402-420 are 270 
conserved in each class of  PBPs. Gly418 closes a hydrophobic pocket that can accommodate 271 
the methyl group of the penultimate D-alanine of the stem pentapeptide, conferring to PBPs a 272 
high specificity for a D-alanine as the fourth residue of the pentapeptide. 273 
Electron density around residues 499-510, a loop that connects  strands β3 and β4 close to the 274 
active site, is weak but sufficient to allow its determination. Disorder of this loop is a general 275 
property of class B PBPs whereas in other classes of PBPs, a small hairpin connects the two 276 
strands [38,43,47-50]. It could be stabilized by interactions with another protein of the 277 
divisome, e.g. for an adequate position and orientation of the active site of PBP3 along with 278 
the transpeptidase active site of PBP1b. The loop could also have a role for accompanying the 279 
displacement of the glycan chain on the surface of PBP3. In a similar manner, a disordered 280 
loop in the glycosyltransferase domain of S. aureus PBP2, a class A PBP homologous to 281 
PBP1b, was proposed to allow the nascent glycan chain to move processively from the donor 282 
site to the acceptor site [51]. 283 
 284 
N-terminal module 285 
The N-terminal module provides three loops (180-190; 202-228; 280-294) and one subdomain 286 
(88-165) for potentially interacting with other proteins of the divisome. The residues between 287 
these loops and subdomain form a series of motifs well conserved in the primary sequence of 288 
class B PBPs [4], forming the junction between the C- and N-terminal modules and tethering 289 
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the loops from the latter to the C-terminal module. Comparison with the structures of other 290 
class B PBPs shows that the relative position between the two modules can vary, suggesting 291 
that the junction between both modules is flexible. Difference between apo and acyl-enzyme 292 
structures of P. aeruginosa PBP3 led to the same conclusion [38]. Figure 3 shows the 293 
structures of S. aureus PBP2a [42] and S. pneumoniae PBP2b [41], with their C-terminal 294 
domain superposed onto that of PBP3, highlighting the fact that the domains equivalent to 295 
PBP388-165 (domain 169-237 for SauPBP2a and domain 104-197 for SpnPBP2b) lie in 296 
different position. Class A PBPs also show a high degree of flexibility between their 297 
glycosyltansferase module and the ensemble made of the linker and the transpeptidase module 298 
[51]. Such flexibility could be necessary for the enzyme to reach its target or be required for  299 
displacement of the divisome along the septum. 300 
The 180-190 loop forms a small β-hairpin exposing Val184 and Asp185 to the solvent. The 301 
length of this loop is characteristic of class B PBPs pertaining to the divisome (PBP3) and is 302 
much longer in class B PBPs acting during elongation (PBP2). The 280-294 loop, from the C-303 
terminal module, is close to the 180-190 loop and is also longer in the PBPs of the elongation 304 
complex than in the PBPs of the divisome. These two loops could thus represent a specific 305 
PBP3 zone of interaction with partners of the divisome, preventing PBP3 to associate with 306 
proteins of the elongation complex or, conversely, preventing PBP2 to associate with proteins 307 
of the divisome. 308 
Electron density is absent for segment 202-228, which again suggests that interactions with a 309 
partner protein may stabilize its tertiary structure in the divisome. Marrec-Fairley et al. [52] 310 
have characterized mutants of the E206-V217 segment consistent with such a role in protein 311 
interaction. R210 seems particularly important, together with residues G57, S61 and L62, for 312 
the recruitment of FtsN [53]. 313 
 314 
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PBP388-165 subdomain 315 
Electron density was very poor for residues between Val88 and Ser185, with only some 316 
secondary structures showing up in the electron density maps. Apparent disorder of domain 317 
88-165 is also observed in N. gonorrhoeae PBP2 [35] and to a lesser extent in Pseudomonas 318 
aeruginosa PBP3 [38], Acinetobacter Baumanii PBP3 [37], Enterococcus faecium PBP5 [54] 319 
and S. pneumoniae PBP2x [40], all of which are class B PBPs. Interaction of this domain with 320 
another protein of the divisome may stabilize its tertiary structure. In order to determine its 321 
three-dimensional structure, the PBP388-165 domain was produced and its structure solved. 322 
The domain crystallizes in P1 with eight molecules in the asymmetric unit. Because of the 323 
high number of copies in the asymmetric unit, molecular replacement using the closely related 324 
domain Val79-Phe151 of P. aeruginosa PBP3 failed to provide a solution, whatever the 325 
Molecular Replacement program used. The structure of the PBP388-165 domain was eventually 326 
determined by single anomalous diffraction using a selenomethionine substituted PBP388-165 327 
crystal and refined over data collected on a crystal of the native PBP388-165 protein. The 328 
electron density is well defined except for residues 132-135 in chain F and for the C-terminal 329 
residue in chains E, G and H. Final Rwork and Rfree values for the PBP388-165 domain are 330 
20.9 % and 26.3 % respectively. The eight molecules in the asymmetric unit are organized in 331 
four pairs with, in each pair, 18 N-terminal residues swapping into the paired molecule (Fig. 332 
4a). The swapped residues represent a two-turn helix and a β-strand that inserts between two 333 
β-strands of the other molecule to form a three stranded β-sheet. Interactions between the two 334 
molecules are numerous and include many hydrogen bonds, salt bridges (e.g. for associated 335 
chains A and C: Asp94A-Arg135C, Glu97A-His160C), hydrophobic clusters (Ile91A is 336 
surrounded by seven leucines or isoleucines from chain C), and an aromatic ring stacking 337 
(Trp92A is sandwiched between Phe136C and His160C) (Fig. 4b). Together, residues 88-105 338 
from one molecule and residues 106-165 from the paired molecule form a small globular 339 
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domain whose tertiary structure, three anti-parallel β-strands flanked by three helices, is 340 
homologous to the equivalent domain of P. aeruginosa PBP3.  341 
Mutations in the E. hirae PBP5190-261 domain, homologous to PBP388-165, support the 342 
hypothesis that this domain is a good candidate to play a role in protein-protein interactions 343 
[55].  Of note is the insertion of 60 residues assembling in four helices in the corresponding 344 
domain of PBPs of subclass B5 [41,56]. 345 
 346 
PBP3 dimers. 347 
PBP3 dimerization was shown in vivo by two-hybrid assay [19,20] and FRET  [12], and the 348 
structure of PBP388-157 suggests that PBP3 dimerization could be reinforced by 3D domain 349 
swapping involving residues 88-105. The weak electronic density around domain 88-165 in 350 
the crystal of PBP357-577 allows the approximate positioning of PBP388-165 structure in the 351 
crystal of PBP357-577. PBP388-165 then faces a symmetric domain with the crystallographic axis 352 
of symmetry at the hinge point where domain swapping occurs in PBP388-165, raising the 353 
possibility that swapping also occurs in the crystal of PBP357-577. Domain swapping in 354 
PBP357-577 would yet involve a twisting of PBP388-165 domain, i.e. symmetrical PBP388-165 355 
domains would not be oriented in the PBP357-577 crystal in the same manner as in the PBP388-356 
165 one. 357 
The oligomerization state of PBP388-165 and PBP357-577 was investigated by Light Scattering 358 
and gel filtration. DLS and SLS experiments carried out on a solution of PBP388-165 suggested 359 
a dimer in solution. The monodisperse distribution observed in DLS provided a hydrodynamic 360 
radius of 18 Å corresponding to the radius of the PBP388-165 dimeric form calculated from the 361 
coordinate file whereas the average molecular mass given by SLS was 27 kDa, which is an 362 
overestimated mass of PBP388-165 dimer due to the strong influence of small quantities of 363 
remaining aggregates on mass calculation. Gel filtration assays carried out with PBP388-165 364 
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provided 2 peaks representing each 50% of the total protein content (Fig. 5a). The second 365 
peak represents PBP388-165 dimers and the first peak accounts for higher order multimers. 366 
From these results, we conclude that, at the concentration used for crystallization, monomers 367 
of PBP388-165 are absent and dimers are predominant in the solution. 368 
DLS analysis of PBP357-577 exhibited unimodal particle-size distributions with an intensity-369 
average hydrodynamic diameter of 48 Å. Hydrodynamic radii calculated from pdb files gives 370 
27 Å and 54 Å for a monomer or a dimer of PBP357-577  respectively, suggesting that a dimer 371 
is predominant in solution. This was confirmed by SLS analysis, which provided a molecular 372 
mass of 108 kDa, corresponding to a PBP357-577 dimer. In gel filtration assays, PBP357-577 was 373 
mainly eluted as a monomer with 5% of dimers (Fig. 5b), which might be explained by the 374 
constant displacement of the equilibrium toward the monomer when it is separated by the size 375 
from the dimer. At the concentration used for crystallization, dimers of PBP357-577 can 376 
predominate in the solution but monomers are also present and it remains unclear if PBP357-377 
577 dimerization results directly from 3D domain swapping.  378 
3D domain swapping is frequently observed as an artefact resulting from crystallization, 379 
without bearing relevance to biological function. Because domain swapping in the PBP357-577 380 
crystal would involve a large twisting of the (88-165) domain and, also, because domain 381 
swapping should stabilize the domain and hence provide a clear electronic density in that 382 
region, the domain swapping observed in the case of PBP388-165 is probably absent in the 383 
PBP357-577 crystal. Moreover, in the full PBP3, domain swapping would extend from residue 384 
105 to the amino terminus and swapping of such a large domain has never been reported. A 385 
role for domain swapping in the in vivo dimerization of PBP3 seems therefore elusive.  386 
 387 
PBP388-165 interactions 388 
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PBP1b, FtsN or FtsW are known to interact with PBP3 but a direct interaction between these 389 
proteins and the PBP388-165 domain could not be detected using affinity chromatography (data 390 
not shown). Nevertheless, PBP388-165 in vitro dimerization by domain swapping could impair 391 
the interaction, if any, of the PBP388-165 domain with one of these proteins and an in vivo 392 
interaction of the domain with PBP1b, FtsN or FtsW cannot be discarded.  393 
The subcomplex FtsQ/FtsL/FtsB could also be involved in the interaction with PBP388-165. 394 
The N-terminal module of PBP3 appears to interact with FtsL in a two-hybrid system [20]. 395 
Lytic transglycosylases represent other potential candidates for an interaction with PBP388-165. 396 
In E. coli, the soluble lytic transglycosylase Slt70 was shown to interact with PBP3 [57], 397 
whereas in N. meningiditis the membrane bound lytic transglycosylase MltA was shown to 398 
interact with PBP2Ng [58], the orthologue  of E. coli PBP3.  399 
We tested the possibility that the PBP388-165 domain could interact with the peptidoglycan. 400 
The binding of PBP357-577 and PBP388-165 to peptidoglycan sacculi was tested by a pull-down 401 
assay (Fig. 6). We showed that a part of PBP357-577, but not PBP388-165, was pelleted with the 402 
sacculi indicating that it has an affinity for the peptidoglycan. On the whole, results indicate 403 
that this region of PBP3 is not essential for its interaction with the murein sacculus although 404 
PBP388-165 dimerization could also perturb a possible interaction with the peptidoglycan.  405 
 406 
Conclusion 407 
PBP3 interacts with many proteins and occupies a central role in the periplasmic component 408 
of the divisome. The structural information brought by the resolution of the PBP3 structure 409 
adds to the available structures of E. coli PBP1b, FtsQ, and FtsN carboxy terminal domain.  410 
The modular organisation and the non-folded nature of the small loops or subdomains 411 
composing the PBP3 N-terminal module suggest that the latter could be involved in protein-412 
protein interactions with partners of the divisome. 413 
 18 
The structure of the PBP388-165 domain, disordered in PBP3, shows a dimerization of the 414 
domain by three dimensional domain swapping that is possible but unlikely in the full length 415 
PBP3. Domain swapping in PBP388-165 domain is unlikely to play a role in the in vivo PBP3 416 
dimerization and a role in protein-protein interaction remains the most attractive hypothesis 417 
for this small domain.  418 
  419 
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Figure legends 427 
 428 
Figure 1 Structure of E. coli PBP3. Cartoon representation of the crystal structure of 429 
PBP357-577. A ribbon trace of modelled loops undefined in the crystal structure is shown in 430 
grey. The active site is indicated by a red sphere. Loops discussed in the text are indicated.  431 
 432 
Figure 2 PBP3 active site. (a) Stereo view of a modelled tripeptide D-Glu-mDap-D-Ala in 433 
the active site of PBP3. The tripeptide (yellow) is modelled as an acyl-enzyme and is bonded 434 
to the active serine shown in green. (b) Stereo view of a cartoon representation of the 435 
transpeptidase active site of PBP3. The oxyanion hole is defined by the nitrogen atoms of 436 
residues 307 and 497. Loop 400-420 is shown in cyan. Nitrogen atoms are shown in blue and 437 
oxygen atoms in red. 438 
 439 
Figure 3 Junction between C- and N-terminal modules. Comparison between the relative 440 
orientation of N and C-terminal modules of PBP3 (blue), S. aureus PBP2a (magenta) and S. 441 
pneumoniae PBP2b (green). The C-terminal domain of SaPBP2a and SpnPBP2b are 442 
superimposed onto the C-terminal domain of PBP3. SaPBP2a (169-237) and SpnPBP2b (104-443 
197) are equivalent to domain 88-165 of PBP3.  444 
 445 
Figure 4 Domain swapping in PBP388-165. (a) PBP388-165 crystal unit cell (space group P1). 446 
The 8 chains are organized by pairs with 18 swapped residues. (b) Interactions between 447 
swapped residues from chains D (yellow) and H (green), including the hydrophobic cluster 448 
around Ile91 (Leu139, Ile151, Leu161), salt bridges (Asp94-Arg135, Glu97-His160 and an 449 
aromatic ring sandwich (His160-Trp92-Phe136). Some labels are omitted for clarity. Nitrogen 450 
atoms are shown in blue and oxygen atoms in red.  451 
 452 
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Figure 5 PBP3 oligomerization. (a) Chromatogram of PBP388-165 gel filtration on a Superdex 453 
75 10/300 GL. The first peak elutes at 12.16 ml and the second at 13.52 ml. Carbonic 454 
anhydrase (31 kDa) elutes at 11.05 ml and lysozyme (14kDa) at 15.25 ml (data not shown). 455 
The buffer was 0.15 M NaCl and 0.1 M Tris, pH 8 1mM EDTA. (b) Chromatogram of 456 
PBP357-577 gel filtration on a Superdex 200 10/300 GL. The first small peak elutes at 13.3 ml, 457 
the second at 14.77 ml. Bovine serum albumin used as a standard elutes at 14.12 ml 458 
(molecular mass 67 kDa, data not shown). The masses calculated on the basis of the mass 459 
standards are 108.5 kDa for the first peak (PBP357-577 dimer) and 58.5 kDa for the second peak 460 
(PBP357-577 monomer). The buffer was 20mM Tris HCl pH 8, 0.5 M NaCl. 461 
 462 
Figure 6. Interaction with peptidoglycan. Pulldown of PBP357-577 (up) and PBP388-165 463 
(down) with and without peptidoglycan sacculi (+ PG and – PG respectively). S, supernatant, 464 
W, washing step, P, pellet. 465 
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 636 
Table 1: Data collection and refinement statistics 637 
Crystal PBP357-577 PBP388-165 
SeMet derivative 
PBP388-165 
PDB code 4BJP  4BJQ 
Data Collection:    
Space group P6122 P1 P1 
Cell Dimensions    
a, b, c (Å) 119.0, 119.0, 139.2 55.8, 55.8, 81.5 56.0, 56.0, 82.3 
α, β, γ (°) 90, 90, 120 75.8, 89.4, 65.3 76.2, 89.1, 66.0 
Resolution range (Å)
a
 82.8 – 2.5 (2.64 – 
2.5) 
49 – 2.7 (2.85-
2.70) 
38.9 - 2.10 
(2.21 – 2.10) 
No. of unique reflections 20753 45763 45669 
Rmerge (%)
a 
16.6 (54.3) 11.7 (47.8) 8.0 (50.8) 
<I>/<σI> a 13.5 (4.9) 8.7 (2.6) 10.2 (2.5) 
Completeness (%)
a
 99.8 (98.8) 95.4 (93.8) 88.5 (95.4) 
Redundancy
 a
 14.0 (10.4) 2.6 (2.6) 3.7 (3.8) 
Refinement:    
Resolution range (Å) 59.5 - 2.5  35.7 – 2.1 
No. of non hydrogen atoms 3409  5467 
Number of water molecules 135  533 
R cryst (%) 19.9  20.8 




Statistics for the highest resolution shell are given in parentheses. 639 
b




RMS deviations from ideal 
Stereochemistry 
   
Bond lengths (Å) 0.012  0.010 
Bond angles (
o
)  1.41  1.19 




34.1  31.9 
Ramachandran plot 
b
    
 Favoured region (%)   98.5  99.7 
 Allowed regions (%)  1.5  0.3 
 Outlier regions (%)  0  0 
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Abstract 26 
In Escherichia coli, penicillin-binding protein 3 (PBP3), also known as FtsI, is a central 27 
component of the divisome, catalyzing cross-linking of the cell wall peptidoglycan during cell 28 
division. PBP3 is mainly periplasmic, with a 23 residues cytoplasmic tail and a single 29 
transmembrane helix. We have solved the crystal structure of a soluble form of PBP3 30 
(PBP357-577) at 2.5 Å revealing the two modules of high molecular weight class B PBPs, a 31 
carboxy terminal module exhibiting transpeptidase activity and an amino terminal module 32 
with of unknown function. To gain additional insight, the PBP3 Val88-Ser165 subdomain 33 
(PBP388-165), for which the electron density is poorly defined in the PBP3 crystal, was 34 
produced and its structure solved by SAD phasing at 2.1 Å. The structure shows a three 35 
dimensional domain swapping with a β-strand of one molecule inserted between two strands 36 
of the paired molecule, suggesting a possible role in PBP357-577 dimerization.  37 
  38 
  39 
 3 
Introduction 40 
The penicillin-binding proteins (PBPs) synthesize and remodel the cell wall peptidoglycan, a 41 
major component of the bacterial cell wall that gives to the cell its shape and rigidity [1-4]. 42 
They are found in all bacteria and represent a major targets in anti-biotherapy, especially for 43 
the widely used -lactam antibiotics. Penicillin-binding proteins belong to the family of acyl-44 
serine transferases and are traditionally separated into high-molecular-weight  (HMW) PBPs 45 
and low-molecular-weight (LMW) PBPs based on molecular weight and sequence homology 46 
[4-6]. The former enzymes act as transpeptidases in vivo and are involved in direct 47 
peptidoglycan synthesis while the latter are carboxypeptidases and endopeptidases [7] thought 48 
to remodel peptidoglycan during the bacterial life cycle but details of their in vivo activity 49 
activities are not well established. The HMW-PBPs group can be subdivided into classes A 50 
and B, the LMW group into classes A, B and C. Class B HMW-PBPs can be further divided 51 
into subclasses and Escherichia coli PBP3 is paradigmatic of subclass B3 that groups class B 52 
PBPs from Gram negative bacteria involved in cell division. Some PBPs from Gram positive 53 
bacteria involved in spore peptidoglycan synthesis also belong to subclass B3, e.g. SpoVD 54 
from Bacillus subtilis. 55 
During cell division, the peptidoglycan is synthesized by the periplasmic part of a 56 
macromolecular complex called the divisome, made up of at least 20 proteins in Escherichia 57 
coli [8]. Cell division is initiated by the polymerization of tubulin homolog FtsZ into a 58 
contractile ring at midcell [9] and the other division proteins are recruited sequentially to the 59 
septal ring. FtsZ first associates with FtsA, ZapA and ZipA that stabilize the FtsZ filaments 60 
and tether them to the cytoplasmic membrane. The divisome then matures with a long delay 61 
between formation of the Z ring and recruitment of the proteins downstream of FtsK[10]. 62 
These proteins involved in septal peptidoglycan synthesis are now thought to be recruited as 63 
subcomplexes, at least FtsQ/L/B [11] and FtsW/PBP3 [12]. FtsN, which contains a SPOR 64 
 4 
peptidoglycan binding domain, is the last protein essential to division protein that localizes at 65 
the septum [13]. Finally, various proteins not essential for septal peptidoglycan synthesis 66 
associate with the divisome: the Tol/Pal complex involved in the invagination of the outer 67 
membrane [14], and the peptidoglycan hydrolase AmiC (and its activator NlpD) that plays an 68 
essential role in the separation of daughter cells separation [15]. Recently, the outer 69 
membrane protein Lpob LpoB was also shown to associate with the divisome and to regulate 70 
peptidoglycan synthesis by interacting with the glycan chain polymerase/transpeptidase 71 
PBP1b [16]. 72 
In E. coli, PBP3 (FtsI) is an essential protein of the divisome, catalyzing peptide cross-bridges 73 
between the glycan chains of the peptidoglycan. PBP3 is involved in many interactions within 74 
the divisome. It interacts directly with PBP1b which localizes at the division site during 75 
septation in a PBP3 dependent fashion [17]. PBP3 works in concert with PBP1b to 76 
incorporate the nascent glycan chain into the existing peptidoglycan [4]. The N-terminal 56 77 
amino acid residues of PBP3 (containing a cytoplasmic peptide, the transmembrane segment 78 
and a short periplasmic peptide) interact with PBP1b in a two-hybrid assay. However other 79 
interacting sites should be present in the periplasmic part of PBP1b and PBP3 [17]. PBP3 also 80 
interacts directly with FtsW and with FtsN, which itself interacts with PBP1b and stimulates 81 
its activity [18]. These proteins are able to form a discrete complex independently of the other 82 
cell division proteins [12]. Interaction of PBP3 with FtsA, FtsK, FtsQ [19] or FtsL [20] were 83 
also reported but the structural details and the sites of interaction between PBP3 and the 84 
proteins of the divisome remain to be elucidated.  85 
The ftsI gene encodes a 588 residues protein of 588 amino acids but proteolytic cleavage 86 
removes 11 amino acids at the C-terminal part of the protein[21]. We have solved the crystal 87 
structure of the periplasmic domain of PBP3 (residues 57-577) at 2.5 Å. We have also 88 
produced, purified, crystallized and solved the structure of the Val88-Ser165 subdomain 89 
 5 
(PBP388-165), a potential protein-protein interaction domain, which was poorly defined in the 90 
electron density map of PBP357-577.  91 
 92 
 93 
Material and Methods 94 
Bacterial strains, oligonucleotides and media: Bacterial strains were E. coli Top 10F’ for 95 
cloning (Invitrogen, USA) and E. coli C41(DE3) for expression [22]. Oligonucleotides were 96 
from Eurogentec. The rich media used were 2XYT (bacto-tryptone 16 g, yeast extract 10 g, 97 
NaCl 5 g, water 1 l, pH 7.0.) or Luria-Bertani (LB) medium supplemented with ampicillin 98 
(100 µg ml
-1
), chloramphenicol (20 or 30 µg ml
-1
), kanamycin (50 µg ml
-1)
 and IPTG (0.5 99 
mM) when appropriate.  100 
 101 
PBP357-577: Production, purification, crystallization, data collection and structure 102 
refinement. 103 
Plasmids used were pDML232 for the PBP3 and pDML237 for SecB [23][12]. Fermentation 104 
of E. coli  strain W3110M  was performed in RFB MIL11/03 at 37°C to over express the 105 
PBP3(57-577), allowing to obtain soluble protein expression at 210 mg/lLitre of culture. 106 
50 g of wet bacterial pellet corresponding to 1 litre of culture were suspended into 150 ml of 107 
100 mM Tris (pH 8), 0.1 mM PMSF buffer, under magnetic stirring in an ice batch for 30 108 
minutes. Mechanical lysis of Bacteria bacteria was performed with a Rannie at 650 bars and 109 
cooling. Cell lysate was centrifuged on a JOUAN SR 20.22 at 42 000 g for 1 hour at 4°C. We 110 
then centrifuged the supernatant on a Beckman XL90 at 100 000 g for 30 minutes at 4°C, in 111 
order to clarify the solution.  112 
The clarified supernatant was loaded on a S-Sepharose Fast Flow column (XK50/30) 113 





ml/min (608 ml/h31 ch/h). Elution was performed with a linear gradient from 100% of buffer 115 
A to 40% of buffer B (buffer A + 1 M Nacl). PBP3 was eluated at about 20% of buffer B. 116 
Eluate was diluted 1/3 in buffer A and. 117 
The eluate was then loaded on an S-Sepharose Hiload (XK16/10) column equilibrated in 118 
buffer A at 30 ch/h588 ml/h. Elution was performed with buffer C (100 mM Tris (pH 8), 10% 119 
glycerol, 10% ethylene glycol, 0.5 M NaCl).  The eluate collected in one column volume was 120 
then purified on a Superdex 200 (XK50/60) column at 15 cm/h294 ml/h to obtain a highly 121 
purified and homogenous protein. 120 mg of purified protein were obtained at 1.6 mg/ml (UV 122 
measurement). N-terminal sequence was checked and confirmed. Circular dichroism analyses 123 
showed that the protein has a stable three-dimensional structure with 30% of alpha-helix. N-124 
terminal sequence was checked and circular dichroism of the aromatic region showed that the 125 
protein has a stable three-dimensional environment with 30% of alpha-helix. The FRET 126 
(resonance energy transfer) measurements showed a rotational coefficient of 38 ns which 127 
demonstrated the monodisperse status of the population with an apparent molecular weight of 128 
53 KDa.  129 
Crystals of PBP357-577 were grown at 20°C by hanging drop vapor diffusion. Crystals were 130 
obtained by mixing 5 µl of a 18 mg/ ml
-1
 protein solution (also containing 0.5 M NaCl and 20 131 
mM Tris, pH 8), 4 µl of well solution (2.5 M ammonium sulfate and 0.1 M N-cyclohexyl-3-132 
aminopropanesulfonic acid (CAPS), pH 10), and 1 µl of 0.1 M NaCl solution. Crystals 133 
appeared after several months and could not be reproduced despite countless attempts. the 134 
apparent very narrow range of crystallization conditions resulted in only some very small 135 
badly diffracting crystals and one crystal diffracting at 2.5 Å. Diffraction data were measured 136 
on Beamline ID29 at the European Synchrotron Radiation Facility (ESRF, Grenoble, France) 137 
and processed using Mosflm [24] and SCALA from the CCP4 program suite. [25] The 138 
structure of PBP3 was solved by molecular replacement with the program PHASER [26] 139 
 7 
using the structure of PBP2 from Neisseria gonorrhoeae (PDB id: 3equ) as the initial search 140 
model. Refinement was carried out using REFMAC5, [27] TLS, [28] and Coot. [29]. The 141 
final refinement statistics are given in Table 1.  142 
 143 
PBP388-165: Production, purification, crystallization, data collection and structure 144 
refinement. 145 
The ftsI fragment encoding PBP388-165 was amplified by PCR using plasmid pMVRI [17] as 146 
template and oligonucleotides  5’-GGACCCGGGGTAAAAGCGATTTGGGCTGACCC-3’ 147 
and 5’-GCCGGATCCTTAAGAC TCTTCACGCAGATGAATCCC-3’ as primers (XmaI and 148 
BamHI are underlined). The PCR fragment was cloned into the pJet1.2/blunt cloning vector 149 
(Fermentas), sequenced, digested with XmaI and BamHI and inserted into the same sites of 150 
plasmid pET-52b(+). The resulting plasmid pDML2042 codes for the PBP388-165 with an N-151 
terminal strep-tag. The strep-tag- PBP388-165 was isolated from E. coli C41(DE3) harbouring 152 
pDML2042 grown at 37° C in 2XYT medium  in the presence of 0.5 mM IPTG for 3h. The 153 
harvested cells were suspended in 40 ml of 100 mM Tris-HCl pH 8.0, 150 mM NaCl, 1mM 154 
EDTA containing an protease inhibitor cocktail protease (Roche) (buffer C), broken 5 times 155 
into a high-pressure homogenizer (Emulsiflex-C3 Avestin Inc.) and centrifuged at 25000g for 156 
40 min. The supernatant was filtered (0.45µ) and applied to a 5 ml Strep-Tactin column IBA 157 
column. After 5 washes with buffer C, the strep-tag-PBP388-165 was eluted in 100 mM Tris-158 
HCl pH8.0, 150 mM NaCl, 1mM EDTA, 2.5mM desthiobiotin. The fractions of interest (5ml) 159 
were dialyzed against 2 L of buffer C with a 3,500 Dalton cut off membrane and analyzed on 160 
by SDS-18% PAGE. About 6 mg of PBP388-165 per liter of culture was were produced and 161 
purified to 90% purity. The strep-tag was removed from PBP388-165 before crystallization. 162 
Crystals of PBP388-165 were grown at 20°C by hanging drop vapor diffusion. Crystals were 163 
obtained by mixing 4 µl of a 7.5 mg/ ml
-1
 protein solution containing 0.15 M NaCl and 0.1 M 164 
 8 
Tris, pH 8 1mM EDTA, and 1 µl of well solution (2 M ammonium sulfate and 0.1 M citrate, 165 
pH 3.5). The structure of PBP388-165 was solved by single anomalous diffraction using a 166 
selenomethionine substituted SePBP388-165 crystal. Selenomethionine substituted SePBP388-165 167 
was expressed by using minimal medium supplemented with selenomethionine and purified 168 
and crystallized as PBP388-165. Diffraction data for the SePBP388-165 crystals were measured on 169 
Beamline PROXIMA 1 at SOLEIL (Paris, France). Data were processed using XDS [30] and 170 
initial structure determination of SePBP388-165 was determined with the help of SHELXC/D/E 171 
[31], Parrott [32] and Buccaneer [33].  172 
Refinement was carried out on native PBP388-165 using REFMAC5, [27] TLS, [28] and Coot. 173 
[29]. Diffraction data for the native PBP388-165 were measured on Beamline BM30A at the 174 
European Synchrotron Radiation Facility (ESRF, Grenoble, France) and processed using 175 
Mosflm [24] and SCALA from the CCP4 program suite. [25] Data and final refinement 176 
statistics are given in Table 1.  177 
 178 
Western blotting: Western blotting was carried out as described [12]. PBP3, PBP1b and 179 
FtsN were revealed with respective polyclonal antibodies and FtsW was probed with 180 
monoclonal anti-HA-Peroxydase (HighAffinity (3F10) Roche). 181 
.  182 
Light Scattering (DLS and SLS).  183 
Dynamic and static light scattering data were recorded on a DynaPro NanoStar instrument 184 
(Wyatt Technology Corporation) operated in batch mode at 20°C and fitted with a laser beam 185 
emitting at 658 nm with power auto-attenuation. Scattering angles were 90° for both DLS 186 
(avalanche photodiode) and SLS (silicon PIN photodetector). Measurements were performed 187 
under buffer conditions and concentration used for crystallogenesis. Samples were filtered on 188 






microcuvette. Data were averaged from 20 acquisitions of the scattered light intensity during 190 
5 s, with a sum of squares error value below 100. Scattering data were analyzed using 191 
DYNAMICS v. 7.1.1.3 software (Wyatt Technology Corp.) that includes the DYNALS 192 
module for distribution analysis in photon correlation spectroscopy. A globular protein model 193 
was used for mass estimation in DLS and a dn/dc value of 0.185 mLl/g for mass calculations 194 
in SLS. Theoretical protein hydrodynamic radii were calculated from pdb files with program 195 
HYDROPRO [34].  196 
 197 
Protein binding to peptidoglycan. Protein binding to peptidoglycan was realized performed 198 
as described in Typas et al. [16]. Briefly, 10 µg of protein was were incubated with a 199 
peptidoglycan suspension of E. coli MC1061. The peptidoglycan was pelleted, washed and 200 
resuspended in 2% SDS. The unbound fraction, the wash fraction and the resuspended pellet 201 
were loaded onanalysed by SDS-18% PAGE. A control sample was realized without 202 
peptidoglycan.  203 
 204 
Gel filtration. Gel filtration experiments were performed on a Superdex 200 10/300 GL and 205 
on a Superdex 75 10/300 GL for PBP357-577 and PBP388-165 respectively. The proteins were 206 
used at the same concentration and in the same buffer as in the crystallogenesis assay and in 207 
DLS. 200 µl of protein were injected. Standard proteins (lysozyme 14.3 KkDa, trypsin 208 
inhibitor 20.1 kKDa, carbonic anhydrase 31 kKDa, bovine serum albumin 66.5 kKDa) were 209 
used for calibration.   210 
 211 
Accession numbers. The atomic coordinates for the crystal structure of PBP357-577 and 212 
PBP388-165 are available at the Protein Data Bank with the accession numbers PDB ID: 4BJP 213 
and 4BJQ.  214 
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Results and discussion 215 
Structure determination 216 
The crystal structure of a soluble form of PBP3, including residues 57 to 577, was solved at 217 
2.5 Å resolution. The structure of PBP3 was solved by molecular replacement using the 218 
structure of PBP2 from Neisseria N. gonorrhoeae (PDB id: 3equ) [35]. PBP3 crystallizes in 219 
space group P6122 with one molecule in the asymmetric unit. The structure was built from 220 
residues 71 to 567 but absence of detectable electronic density did not allow structure 221 
determination for residues 93-112, 119-141, 152-162, 202-228 and 537-543. PBP3 structural 222 
information have beenwas supplemented by independently solving the Val88-Ser165 223 
subdomain structure (see below). Final Rcryst and Rfree values for the PBP3 structure 224 
determination are 19.9 % and 24.5 % respectively.  225 
The overall fold of periplasmic PBP3 is bimodular (Fig. 1a). The C-terminal module is, 226 
responsible for the transpeptidase activity, is associated to but no clear function has been 227 
assigned yet to the N-terminal module of the construct, for which no clear function has been 228 
assigned yet. 229 
 230 
.  231 
Transpeptidase module and active site 232 
The C-terminal module shares its overall fold with the transpeptidase domain found in all 233 
PBPs [5,36]. Structure-based alignments of the PBP3 transpeptidase domain show little 234 
structural deviations from the corresponding domains of class B3 PBPs with r.m.s.deviations 235 
of 1.3 Å (Acitenobacter baumanii PBP3 [37]), 1.3 Å (Pseudomonas aeruginosa PBP3 [38] 236 
and 1.4 Å (N.gonorrhoeae PBP2 [35] and larger deviations for class B PBPs from other 237 
subgroups (1.7 Å, 2.1 Å,  2.1 Å, and 2.1 Å for Mycobacterium tuberculosis PBPA [39], 238 
Streptococcus pneumoniae PBP2x [40], S. pneumoniae PBP2b [41] and Staphylococcus 239 
aureus PBP2a [42], respectively). The active site responsible for the transpeptidase activity of 240 
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PBP3 is located in a long groove that can accommodate the carboxy-terminal residues of the 241 
PBP3 natural substrate, the peptidoglycan stem pentapeptide L-Ala-γ-D-Glu-meso-242 
diaminopimelic acid (mDAP)-D-Ala-D-Ala (Fig 2a).  243 
The transpeptidase activity of PBP3 depends uponrelies on eight residues, Ser307, Lys310, 244 
Ser359, Asn361, Lys494, Thr495, Gly496 and Thr497, found with few exceptions in all 245 
penicillin-binding enzymes (Fig. 21b).  These residues form three conserved sequence motifs 246 
(Ser-Xaa-Xaa-Lys, Ser-Xaa-Asn and Lys-Thr-Gly-Thr) and are also responsible for the 247 
binding of β-lactam antibiotics to the active site of PBPs [5].  248 
The mechanism leading to linkage between the stem peptides of two glycan chains involves 249 
an acyl-enzyme formed between the active serine and the penultimate D-Ala of one stem 250 
peptide, releasing the ultimate D-Ala. In this mechanism, the nucleophylicity of the active 251 
serine Ser307 would be enhanced by Lys310, and Ser359 would be important for back-252 
donation of the proton to the active serine during the acylation step. Deacylation involves the 253 
attack of the acyl bond by the free amine group of a second stem peptide diaminopimelic acid. 254 
Lys494 could play an important role in deacylation in concert with Ser359, as suggested for 255 
other PBPs [43-45]. 256 
Asn361 should be important for proper positioning of the interpeptidic amide group linking 257 
the penultimate D-Ala to the diaminopimelic acid residue. Substitution of Asn361 by a serine 258 
causes a dramatic change in pole shape [46]. The pointed polar caps observed in the E. coli 259 
mutant harboring this mutation appeared to be associated with the activity of PBP3. Asn361 260 
differentiates PBP3 from its elongation homologue PBP2. The presence of an aspartic acid at 261 
this position in E. coli PBP2 and more generally in all PBPs of class B2(, which contains 262 
Gram negative class B PBPs associated to elongation,) is a noticeable exception to the 263 
conservation of this residue in peptidoglycan synthesizing PBPs. The nature of the amino-acid 264 
should be of importance for the fine structural conformation of peptidoglycan. 265 
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Finally, both threonine residues of the Lys-Thr-Gly-Thr motif should serve as an anchor to the 266 
C-terminal carboxylate group of the pentapeptide. They are found hydrogen bonded to the 267 
penultimate D-Ala carboxylate in structures of DD-peptidases in complex with peptide 268 
fragments [45,47]. 269 
In all ligand-free PBP-structures a water molecule is observed in the oxyanion hole. In PBP3, 270 
the oxyanion hole, defined by the amine groups of residues 307 and 497, is unexpectedly 271 
occupied by the hydroxyl group of Tyr514 that is distant byat 2.7 Å from Ser307N and 3.25 Å 272 
from Thr497N (Fig. 1b2b). Sequence alignment shows that Tyr514 is unique to PBP3 among 273 
class B PBPs. The side chain of Tyr514 is free to easily rotate and liberate the oxyanion hole 274 
and should not play a particular role in transpeptidation. 275 
The rear side of the PBP3 active site is made of residues Phe417-Gly-Tyr-Gly (Fig. 1b2b). 276 
The motif Tyr/Phe/Ile-Gly-Tyr/Gln-Gly and the conformation tertiary structure of the 277 
segment 402-420 are conserved in each class of all PBPs. Gly418 closes a hydrophobic 278 
pocket that can accommodate the methyl group of the penultimate D-alanine of the stem 279 
pentapeptide, conferring to PBPs a high specificity for a D-alanine as the fourth residue of the 280 
pentapeptide. 281 
Electron density around residues 499-510, a loop that connects two strands β3 and β4 close to 282 
the active site, is weak but sufficient to allow its determination. Disorder of this loop is a 283 
general property of class B PBPs whereas in other classes of PBPs, a small hairpin connects 284 
the two strands [38,43,47-50]. It could be stabilized by interactions with another protein of the 285 
divisome, e.g. for an adequate position and orientation of the active site of PBP3 along with 286 
the transpeptidase active site of PBP1b. The loop could also have a role for accompanying the 287 
displacement of the glycan chain on the surface of PBP3. In a similar manner, a disordered 288 
loop in the glycosyltransferase domain of Staphylococcus S. aureus PBP2, a class A PBP 289 
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homologous to PBP1b, was proposed to allow the nascent glycan chain to move processively 290 
from the donor site to the acceptor site [51]. 291 
 292 
N-terminal module 293 
The N-terminal module provides three loops (180-190; 202-228; 280-294) and one subdomain 294 
(88-165) for potentially interacting with other proteins of the divisome. The residues between 295 
these loops and subdomain form a series of motifs well conserved in the primary sequence of 296 
class B PBPs [4], forming the junction between the C- and N-terminal modules and tethering 297 
the loops from the latter to the C-terminal module. Comparison with the structures of other 298 
class B PBPs shows that the relative position between the two modules can vary, provides 299 
evidencesuggesting that the junction between both modules is flexible. Difference between 300 
apo and acyl-enzyme structures of P. aeruginosa PBP3 led to the same conclusion [38]. 301 
Figure 3 shows the structures of S. aureus PBP2a [42] and S. pneumoniae PBP2b [41], with 302 
their C-terminal domain superposed onto that of PBP3, highlighting the fact that the domains 303 
equivalent to PBP388-165 (domain 169-237 for SauPBP2a and domain 104-197 for SpnPBP2b) 304 
lie in different position. Class A PBPs also show a high degree of flexibility between their 305 
glycosyltansferase module and the ensemble made of the linker and the transpeptidase module 306 
[51]. Such flexibility could be necessary for the enzyme to reach its target or be required for a 307 
processive displacement of the divisome along the septum. 308 
The 180-190 loop forms a small β-hairpin exposing Val184 and Asp185 to the solvent. The 309 
length of this loop is characteristic of class B PBPs pertaining to the divisome (PBP3) and is 310 
much longer in class B PBPs acting during elongation (PBP2). The 280-294 loop, from the C-311 
terminal module, is close to the 180-190 loop and is also longer in the PBPs of the elongation 312 
complex than in the PBPs of the divisome. These two loops could thus represent a specific 313 






proteins of the elongation complex or, conversely, preventing PBP2 to associate with proteins 315 
of the divisome. 316 
Electron density is absent for segment 202-228, which again suggests that interactions with a 317 
partner protein may stabilize its tertiary structure in the divisome. Marrec-Ffairley et al. [52] 318 
have characterized mutants of the E206-V217 segment consistent with such a role in protein 319 
interaction. R210 seems particularly important, together with residues G57, S61 and L62, for 320 
the recruitment of FtsN [53]. 321 
 322 
PBP388-165 subdomain 323 
Electron density was very poor for residues between Val88 and Ser185, with only some 324 
secondary structures showing up in the electron density maps. Apparent disorder of domain 325 
88-165 is also observed in Neisseria N. gonorrhoeae PBP2 [35] and to a lesser extent in 326 
Pseudomonas aeruginosa PBP3 [38], Acetinobacter Acinetobacter Baumanii PBP3 [37], 327 
Enterococcus faecium PBP5 [54] and Streptococcus S. pneumoniae PBP2x [40], all of which 328 
are class B PBPs. Interaction of this domain with another protein of the divisome may 329 
stabilize its tertiary structure. In order to determine its three-ridimensional structure, the 330 
PBP388-165 domain was produced and its structure solved. 331 
The domain crystallizes in P1 with eight molecules in the asymmetric unit. Because of the 332 
high number of copies in the asymmetric unit, molecular replacement using the closely related 333 
domain Val79-Phe151 of P. aeruginosa PBP3 failed to provide a solution, whatever the 334 
Molecular Replacement program used. The structure of the PBP388-165 domain was eventually 335 
determined by single anomalous diffraction using a selenomethionine substituted PBP388-165 336 
crystal and refined over data collected on a crystal of the native PBP388-165 protein. The 337 
electron density is well defined except for residues 132-135 in chain F and for the C-terminal 338 
residue in chains E, G and H. Final Rwork and Rfree values for the PBP388-165 domain are 339 
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20.9 % and 26.3 % respectively. The eight molecules in the asymmetric unit are organized in 340 
four pairs with, in each pair, 18 N-terminal residues swapping into the paired molecule 341 
(Figure Fig. 2a4a). The swapped residues represent a two-turn helix and a β-strand that inserts 342 
between two β-strands of the other molecule to form a three stranded β-sheet. Interactions 343 
between the two molecules are numerous and include many hydrogen bonds, salt bridges (e.g. 344 
for associated chains A and C: Asp94A-Arg135C, Glu97A-His160C), hydrophobic clusters 345 
(Ile91A is surrounded by seven leucines or isoleucines from chain C), and an aromatic ring 346 
stacking (Trp92A is sandwiched between Phe136C and His160C) (Figure Fig. 2b4b). 347 
Together, residues 88-105 from one molecule and residues 106-165 from the paired molecule 348 
form a small globular domain whose tertiary structure, three anti-parallel β-strands flanked by 349 
three helices, is homologous to the equivalent domain of P. aeruginosa PBP3.  350 
Mutations in the E. hirae PBP5190-261 domain, homologous to PBP388-165, have 351 
accreditedsupport the hypothesis that this domain is a good candidate to play a role in protein-352 
protein interactions [55].  Of note is the insertion of 60 residues assembling in four helices in 353 
the corresponding domain of PBPs of subclass B5 [41,56]. 354 
 355 
PBP3 dimers. 356 
PBP3 dimerization was shown in vivo by two-hybrid assay [19,20] and FRET  [12], and the 357 
structure of PBP388-157 suggests that PBP3 dimerization could be reinforced by 3D domain 358 
swapping involving residues 88-105. The weak electronic density around domain 88-165 in 359 
the crystal of PBP357-577 allows the approximate positioning of PBP388-165 structure in the 360 
crystal of PBP357-577. PBP388-165 then faces a symmetric domain with the crystallographic axis 361 
of symmetry at the hinge point where domain swapping occurs in PBP388-165, raising the 362 
possibility that swapping also occurs in the crystal of PBP357-577. Domain swapping in the 363 
PBP357-577 would yet involve a twisting of PBP388-165 domain, i.e. symmetrical PBP388-165 364 
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domains would not be oriented in the PBP357-577 crystal in the same manner as in the PBP388-365 
165 one. 366 
The oligomerization state of PBP388-165 and PBP357-577 was investigated by Light Scattering 367 
and gel filtration. DLS and SLS experiments carried out on a solution of PBP388-165 suggested 368 
a dimer in solution. The monodisperse distribution observed in DLS provided a hydrodynamic 369 
radius of 18 Å corresponding to the radius of the PBP388-165 dimeric form calculated from the 370 
coordinate file whereas the average molecular mass given by SLS was 27 kDa, which is an 371 
overestimated mass of PBP388-165 dimer due to the strong influence on mass calculation of 372 
small quantities of remaining aggregates on mass calculation. Gel filtration assays carried out 373 
with PBP388-165 provided 2 peaks representing each 50% of the total protein content 374 
(Supplementary figure 1Fig. 5a). The second peak represents PBP388-165 dimers and the first 375 
peak accounts for higher order multimers. From these results, we conclude that, at the 376 
concentration used for crystallization, monomers of PBP388-165 are absent and dimers are 377 
predominant in the solution. 378 
DLS analysis of PBP357-577 exhibited unimodal particle-size distributions with an intensity-379 
average hydrodynamic diameter of 48 Å. Hydrodynamic radii calculated from pdb files gives 380 
27 Å and 54 Å for a monomer or a dimer of PBP357-577  respectively, suggesting that a dimer 381 
is predominant in solution. This was confirmed by SLS analysis, which provided a molecular 382 
mass of 108 kDa, corresponding to a PBP357-577 dimer. In gel filtration assays, PBP357-577 was 383 
mainly eluted as a monomer with 5% of dimers (Supplementary figure 2Fig. 5b), which might 384 
be explained by the constant displacement of the equilibrium toward the monomer when it is 385 
separated by the size from the dimer. At the concentration used for crystallization, dimers of 386 
PBP357-577 can predominate in the solution but monomers are also present and it remains 387 
unclear if PBP357-577 dimerization results directly from 3D domain swapping.  388 
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3D domain swapping is frequently observed as an artefact resulting from crystallization, 389 
without bearing relevance to biological function. Because domain swapping in the PBP357-577 390 
crystal would involve a large twisting of the (88-165) domain and, also, because domain 391 
swapping should stabilize the domain and hence provide a clear electronic density in that 392 
region, the domain swapping observed in the case of PBP388-165 is probably absent in the 393 
PBP357-577 crystal. Moreover, in the full PBP3, domain swapping would extend from residue 394 
105 to the amino terminus and swapping of such a large domain has never been reported. A 395 
role for domain swapping in the in vivo dimerization of PBP3 seems therefore elusive.  396 
 397 
PBP388-165 interactions 398 
PBP1b, FtsN or FtsW are known to interact with PBP3 but a direct interaction between these 399 
proteins and the PBP388-165 domain could not be detected using affinity chromatography (data 400 
not shown). Nevertheless, PBP388-165 in vitro dimerization by domain swapping could impair 401 
the interaction, if any, of the PBP388-165 domain with one of these proteins and an in vivo 402 
interaction of the domain with PBP1b, FtsN or FtsW cannot be discarded.  403 
The subcomplex FtsQ/FtsL/FtsB could also be involved in the interaction with PBP388-165. 404 
The N-terminal module of PBP3 appears to interact with FtsL in a two-hybrid system [20]. 405 
Lytic transglycosylases represent other potential candidates for an interaction with PBP388-165. 406 
In E. coli, the soluble lytic transglycosylase Slt70 was shown to interact with PBP3 [57], 407 
whereas in N. meningiditis the membrane bound lytic transglycosylase MltA was shown to 408 
interact with PBP2Ng [58], the orthologue  of E. coli PBP3.  409 
We tested the possibility that the PBP388-165 domain could interact with the peptidoglycan. 410 
The binding of PBP357-577 and PBP388-165 to peptidoglycan sacculi was tested by a pull-down 411 
assay (Supplementary figure 3Fig. 6). We showed that a part of PBP357-577, but not PBP388-165, 412 
was pelleted with the sacculi indicating that it has an affinity for the peptidoglycan. On the 413 
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whole, results indicate that this region of PBP3 is not essential for its interaction with the 414 
murein sacculus although PBP388-165 dimerization could also perturb a possible interaction 415 
with the peptidoglycan.  416 
 417 
Conclusion 418 
PBP3 interacts with many proteins and occupies a central role in the periplasmic component 419 
of the divisome. The structural information brought by the resolution of the PBP3 structure 420 
adds to the available structures of E. coli PBP1b, FtsQ, and FtsN carboxy terminal domain.  421 
The modular organisation and the non-folded nature of the small loops or subdomains 422 
composing the PBP3 N-terminal module suggest that the latter could be involved in protein-423 
protein interactions with partners of the divisome. 424 
The structure of the PBP388-165 domain, disordered in PBP3, shows a dimerization of the 425 
domain by three dimensional domain swapping that is possible but unlikely in the full length 426 
PBP3. Domain swapping in PBP388-165 domain is unlikely to play a role in the in vivo PBP3 427 
dimerization and a role in protein-protein interaction remains the most attractive hypothesis 428 
for this small domain.  429 
  430 
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Figure legends 444 
 445 
Figure 1 Structure of E. coli PBP3. (a) View of the crystal structure of PBP3 showing the 446 
penicillin-binding module in orange and the amino-terminal periplasmic module in blue. 447 
Modelled loops undefined in the crystal structure are shown in lightblue. The transmembrane 448 
helix (not in the PBP3 construct) is shown in grey. The active site is indicated by a green 449 
sphere. The cytoplasmic domain is not shown. Loops discussed in the text are indicated. (b) 450 
PBP3 transpeptidase active site. Cartoon-stick representation of the transpeptidase active site 451 
of PBP3. Strand delineating the right of the active site is shown in sticks to unhide tyr514 452 
(green). The oxyanion hole is defined by the nitrogen atoms of residues 307 and 497. Loop 453 
400-420 is shown in cyan. Nitrogen atoms are shown in blue and oxygen atoms in red. 454 
 455 
Figure 2 Domain swapping in PBP388-165. (a) PBP388-165 crystal unit cell (space group P1). 456 
The 8 chains are organized by pairs with 18 swapped residues. (b) Interactions between 457 
swapped residues from chains D (yellow) and H (green), including the hydrophobic cluster 458 
around Ile91 (Leu139, Ile151, Leu161), salt bridges (Asp94-Arg135, Glu97-His160 and an 459 
aromatic ring sandwich (His160-Trp92-Phe136). Some labels are omitted for clarity. Nitrogen 460 
atoms are shown in blue and oxygen atoms in red.  461 
 462 
Figure 1 Structure of E. coli PBP3. Cartoon representation of the crystal structure of 463 
PBP357-577. A ribbon trace of modelled loops undefined in the crystal structure is shown in 464 
grey. The active site is indicated by a red sphere. Loops discussed in the text are indicated.  465 
 466 
Figure 2 PBP3 active site. (a) Stereo view of a modelled tripeptide D-Glu-mDap-D-Ala in 467 
the active site of PBP3. The tripeptide (yellow) is modelled as an acyl-enzyme and is bonded 468 
to the active serine shown in green. (b) Stereo view of a cartoon representation of the 469 
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transpeptidase active site of PBP3. The oxyanion hole is defined by the nitrogen atoms of 470 
residues 307 and 497. Loop 400-420 is shown in cyan. Nitrogen atoms are shown in blue and 471 
oxygen atoms in red. 472 
 473 
Figure 3 Junction between C- and N-terminal modules. Comparison between the relative 474 
orientation of N and C-terminal modules of PBP3 (blue), S. aureus PBP2a (magenta) and S. 475 
pneumoniae PBP2b (green). The C-terminal domain of SaPBP2a and SpnPBP2b are 476 
superimposed onto the C-terminal domain of PBP3. SaPBP2a (169-237) and SpnPBP2b (104-477 
197) are equivalent to domain 88-165 of PBP3.  478 
 479 
Figure 4 Domain swapping in PBP388-165. (a) PBP388-165 crystal unit cell (space group P1). 480 
The 8 chains are organized by pairs with 18 swapped residues. (b) Interactions between 481 
swapped residues from chains D (yellow) and H (green), including the hydrophobic cluster 482 
around Ile91 (Leu139, Ile151, Leu161), salt bridges (Asp94-Arg135, Glu97-His160 and an 483 
aromatic ring sandwich (His160-Trp92-Phe136). Some labels are omitted for clarity. Nitrogen 484 
atoms are shown in blue and oxygen atoms in red.  485 
 486 
Figure 5 PBP3 oligomerization. (a) Chromatogram of PBP388-165 gel filtration on a Superdex 487 
75 10/300 GL. The first peak elutes at 12.16 ml and the second at 13.52 ml. Carbonic 488 
anhydrase (31 kDa) elutes at 11.05 ml and lysozyme (14kDa) at 15.25 ml (data not shown). 489 
The buffer was 0.15 M NaCl and 0.1 M Tris, pH 8 1mM EDTA. (b) Chromatogram of 490 
PBP357-577 gel filtration on a Superdex 200 10/300 GL. The first small peak elutes at 13.3 ml, 491 
the second at 14.77 ml. Bovine serum albumin used as a standard elutes at 14.12 ml 492 
(molecular mass 67 kDa, data not shown). The masses calculated on the basis of the mass 493 
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standards are 108.5 kDa for the first peak (PBP357-577 dimer) and 58.5 kDa for the second peak 494 
(PBP357-577 monomer). The buffer was 20mM Tris HCl pH 8, 0.5 M NaCl. 495 
 496 
Figure 6. Interaction with peptidoglycan. Pulldown of PBP357-577 (up) and PBP388-165 497 
(down) with and without peptidoglycan sacculi (+ PG and – PG respectively). S, supernatant, 498 
W, washing step, P, pellet. 499 




1. Vollmer W, Blanot D, de Pedro MA (2008) Peptidoglycan structure and architecture. 503 
FEMS Microbiol Rev 32: 149-167. 504 
2. Young KD (2003) Bacterial shape. Mol Microbiol 49: 571-580. 505 
3. Spratt BG, Pardee AB (1975) Penicillin-binding proteins and cell shape in E. coli. Nature 506 
254: 516-517. 507 
4. Sauvage E, Kerff F, Terrak M, Ayala JA, Charlier P (2008) The penicillin-binding proteins: 508 
structure and role in peptidoglycan biosynthesis. FEMS Microbiol Rev 32: 234-258. 509 
5. Ghuysen JM (1991) Serine beta-lactamases and penicillin-binding proteins. Annu Rev 510 
Microbiol 45: 37-67. 511 
6. Macheboeuf P, Contreras-Martel C, Job V, Dideberg O, Dessen A (2006) Penicillin 512 
binding proteins: key players in bacterial cell cycle and drug resistance processes. 513 
FEMS Microbiol Rev 30: 673-691. 514 
7. Goffin C, Ghuysen JM (1998) Multimodular penicillin-binding proteins: an enigmatic 515 
family of orthologs and paralogs. Microbiol Mol Biol Rev 62: 1079-1093. 516 
8. Errington J, Daniel RA, Scheffers DJ (2003) Cytokinesis in bacteria. Microbiol Mol Biol 517 
Rev 67: 52-65, table of contents. 518 
9. Margolin W (2005) FtsZ and the division of prokaryotic cells and organelles. Nat Rev Mol 519 
Cell Biol 6: 862-871. 520 
10. Aarsman ME, Piette A, Fraipont C, Vinkenvleugel TM, Nguyen-Disteche M, et al. (2005) 521 
Maturation of the Escherichia coli divisome occurs in two steps. Mol Microbiol 55: 522 
1631-1645. 523 
11. Buddelmeijer N, Beckwith J (2004) A complex of the Escherichia coli cell division 524 
proteins FtsL, FtsB and FtsQ forms independently of its localization to the septal 525 
region. Mol Microbiol 52: 1315-1327. 526 
12. Fraipont C, Alexeeva S, Wolf B, van der Ploeg R, Schloesser M, et al. (2011) The integral 527 
membrane FtsW protein and peptidoglycan synthase PBP3 form a subcomplex in 528 
Escherichia coli. Microbiology 157: 251-259. 529 
13. Dai K, Xu Y, Lutkenhaus J (1993) Cloning and characterization of ftsN, an essential cell 530 
division gene in Escherichia coli isolated as a multicopy suppressor of ftsA12(Ts). J 531 
Bacteriol 175: 3790-3797. 532 
14. Gerding MA, Ogata Y, Pecora ND, Niki H, de Boer PA (2007) The trans-envelope Tol-533 
Pal complex is part of the cell division machinery and required for proper outer-534 
membrane invagination during cell constriction in E. coli. Mol Microbiol 63: 1008-535 
1025. 536 
15. Bernhardt TG, de Boer PA (2003) The Escherichia coli amidase AmiC is a periplasmic 537 
septal ring component exported via the twin-arginine transport pathway. Mol 538 
Microbiol 48: 1171-1182. 539 
16. Typas A, Banzhaf M, van den Berg van Saparoea B, Verheul J, Biboy J, et al. (2010) 540 
Regulation of peptidoglycan synthesis by outer-membrane proteins. Cell 143: 1097-541 
1109. 542 
17. Bertsche U, Kast T, Wolf B, Fraipont C, Aarsman ME, et al. (2006) Interaction between 543 
two murein (peptidoglycan) synthases, PBP3 and PBP1B, in Escherichia coli. Mol 544 
Microbiol 61: 675-690. 545 
18. Muller P, Ewers C, Bertsche U, Anstett M, Kallis T, et al. (2007) The essential cell 546 
division protein FtsN interacts with the murein (peptidoglycan) synthase PBP1B in 547 
Escherichia coli. J Biol Chem 282: 36394-36402. 548 
 24 
19. Di Lallo G, Fagioli M, Barionovi D, Ghelardini P, Paolozzi L (2003) Use of a two-hybrid 549 
assay to study the assembly of a complex multicomponent protein machinery: 550 
bacterial septosome differentiation. Microbiology 149: 3353-3359. 551 
20. Karimova G, Dautin N, Ladant D (2005) Interaction network among Escherichia coli 552 
membrane proteins involved in cell division as revealed by bacterial two-hybrid 553 
analysis. J Bacteriol 187: 2233-2243. 554 
21. Nagasawa H, Sakagami Y, Suzuki A, Suzuki H, Hara H, et al. (1989) Determination of 555 
the cleavage site involved in C-terminal processing of penicillin-binding protein 3 of 556 
Escherichia coli. J Bacteriol 171: 5890-5893. 557 
22. Miroux B, Walker JE (1996) Over-production of proteins in Escherichia coli: mutant hosts 558 
that allow synthesis of some membrane proteins and globular proteins at high levels. J 559 
Mol Biol 260: 289-298. 560 
23. Fraipont C, Adam M, Nguyen-Disteche M, Keck W, Van Beeumen J, et al. (1994) 561 
Engineering and overexpression of periplasmic forms of the penicillin-binding protein 562 
3 of Escherichia coli. Biochem J 298 ( Pt 1): 189-195. 563 
24. Leslie AGW (1991) Molecular data processing. Crystallographic Computing 5: 50-61. 564 
25. CCP4 (1994) The CCP4 suite: programs for protein crystallography. Acta Crystallogr D 565 
Biol Crystallogr 50: 760-763. 566 
26. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, et al. (2007) 567 
Phaser crystallographic software. J Appl Crystallogr 40: 658-674. 568 
27. Murshudov GN, Vagin AA, Dodson EJ (1997) Refinement of macromolecular structures 569 
by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr 53: 240-255. 570 
28. Painter J, Merritt EA (2006) Optimal description of a protein structure in terms of multiple 571 
groups undergoing TLS motion. Acta Crystallogr D Biol Crystallogr 62: 439-450. 572 
29. Emsley P, Cowtan K (2004) Coot: model-building tools for molecular graphics. Acta 573 
Crystallogr D Biol Crystallogr 60: 2126-2132. 574 
30. Kabsch W (2010) Integration, scaling, space-group assignment and post-refinement. Acta 575 
Crystallogr D Biol Crystallogr 66: 133-144. 576 
31. Sheldrick GM (2010) Experimental phasing with SHELXC/D/E: combining chain tracing 577 
with density modification. Acta Crystallogr D Biol Crystallogr 66: 479-485. 578 
32. Zhang KY, Cowtan K, Main P (1997) Combining constraints for electron-density 579 
modification. Methods Enzymol 277: 53-64. 580 
33. Cowtan K (2006) The Buccaneer software for automated model building. 1. Tracing 581 
protein chains. Acta Crystallogr D Biol Crystallogr 62: 1002-1011. 582 
34. Garcia De La Torre J, Huertas ML, Carrasco B (2000) Calculation of hydrodynamic 583 
properties of globular proteins from their atomic-level structure. Biophys J 78: 719-584 
730. 585 
35. Powell AJ, Tomberg J, Deacon AM, Nicholas RA, Davies C (2009) Crystal structures of 586 
penicillin-binding protein 2 from penicillin-susceptible and -resistant strains of 587 
Neisseria gonorrhoeae reveal an unexpectedly subtle mechanism for antibiotic 588 
resistance. J Biol Chem 284: 1202-1212. 589 
36. Massova I, Mobashery S (1998) Kinship and diversification of bacterial penicillin-binding 590 
proteins and beta-lactamases. Antimicrob Agents Chemother 42: 1-17. 591 
37. Han S, Caspers N, Zaniewski RP, Lacey BM, Tomaras AP, et al. (2011) Distinctive 592 
attributes of beta-lactam target proteins in Acinetobacter baumannii relevant to 593 
development of new antibiotics. J Am Chem Soc 133: 20536-20545. 594 
38. Sainsbury S, Bird L, Rao V, Shepherd SM, Stuart DI, et al. (2011) Crystal structures of 595 
penicillin-binding protein 3 from Pseudomonas aeruginosa: comparison of native and 596 
antibiotic-bound forms. J Mol Biol 405: 173-184. 597 
 25 
39. Fedarovich A, Nicholas RA, Davies C (2010) Unusual conformation of the SxN motif in 598 
the crystal structure of penicillin-binding protein A from Mycobacterium tuberculosis. 599 
J Mol Biol 398: 54-65. 600 
40. Pares S, Mouz N, Petillot Y, Hakenbeck R, Dideberg O (1996) X-ray structure of 601 
Streptococcus pneumoniae PBP2x, a primary penicillin target enzyme. Nat Struct Biol 602 
3: 284-289. 603 
41. Contreras-Martel C, Dahout-Gonzalez C, Martins Ados S, Kotnik M, Dessen A (2009) 604 
PBP active site flexibility as the key mechanism for beta-lactam resistance in 605 
pneumococci. J Mol Biol 387: 899-909. 606 
42. Lim D, Strynadka NC (2002) Structural basis for the beta lactam resistance of PBP2a 607 
from methicillin-resistant Staphylococcus aureus. Nat Struct Biol 9: 870-876. 608 
43. Nicola G, Peddi S, Stefanova M, Nicholas RA, Gutheil WG, et al. (2005) Crystal structure 609 
of Escherichia coli penicillin-binding protein 5 bound to a tripeptide boronic acid 610 
inhibitor: a role for Ser-110 in deacylation. Biochemistry 44: 8207-8217. 611 
44. Dzhekieva L, Rocaboy M, Kerff F, Charlier P, Sauvage E, et al. (2010) Crystal structure 612 
of a complex between the Actinomadura R39 DD-peptidase and a peptidoglycan-613 
mimetic boronate inhibitor: interpretation of a transition state analogue in terms of 614 
catalytic mechanism. Biochemistry 49: 6411-6419. 615 
45. Sauvage E, Duez C, Herman R, Kerff F, Petrella S, et al. (2007) Crystal Structure of the 616 
Bacillus subtilis Penicillin-binding Protein 4a, and its Complex with a Peptidoglycan 617 
Mimetic Peptide. J Mol Biol. 618 
46. Taschner PE, Ypenburg N, Spratt BG, Woldringh CL (1988) An amino acid substitution 619 
in penicillin-binding protein 3 creates pointed polar caps in Escherichia coli. J 620 
Bacteriol 170: 4828-4837. 621 
47. Chen Y, Zhang W, Shi Q, Hesek D, Lee M, et al. (2009) Crystal structures of penicillin-622 
binding protein 6 from Escherichia coli. J Am Chem Soc 131: 14345-14354. 623 
48. Kishida H, Unzai S, Roper DI, Lloyd A, Park SY, et al. (2006) Crystal structure of 624 
penicillin binding protein 4 (dacB) from Escherichia coli, both in the native form and 625 
covalently linked to various antibiotics. Biochemistry 45: 783-792. 626 
49. Sung MT, Lai YT, Huang CY, Chou LY, Shih HW, et al. (2009) Crystal structure of the 627 
membrane-bound bifunctional transglycosylase PBP1b from Escherichia coli. Proc 628 
Natl Acad Sci U S A 106: 8824-8829. 629 
50. Sauvage E, Kerff F, Fonzé E, Herman R, Schoot B, et al. (2002) The 2.4-A crystal 630 
structure of the penicillin-resistant penicillin-binding protein PBP5fm from 631 
Enterococcus faecium in complex with benzylpenicillin. Cell Mol Life Sci 59: 1223-632 
1232. 633 
51. Lovering AL, De Castro L, Strynadka NC (2008) Identification of dynamic structural 634 
motifs involved in peptidoglycan glycosyltransfer. J Mol Biol 383: 167-177. 635 
52. Marrec-Fairley M, Piette A, Gallet X, Brasseur R, Hara H, et al. (2000) Differential 636 
functionalities of amphiphilic peptide segments of the cell-septation penicillin-binding 637 
protein 3 of Escherichia coli. Mol Microbiol 37: 1019-1031. 638 
53. Wissel MC, Weiss DS (2004) Genetic analysis of the cell division protein FtsI (PBP3): 639 
amino acid substitutions that impair septal localization of FtsI and recruitment of FtsN. 640 
J Bacteriol 186: 490-502. 641 
54. Sauvage E, Kerff F, Fonze E, Herman R, Schoot B, et al. (2002) The 2.4-A crystal 642 
structure of the penicillin-resistant penicillin-binding protein PBP5fm from 643 
Enterococcus faecium in complex with benzylpenicillin. Cell Mol Life Sci 59: 1223-644 
1232. 645 
 26 
55. Leimanis S, Hoyez N, Hubert S, Laschet M, Sauvage E, et al. (2006) PBP5 646 
complementation of a PBP3 deficiency in Enterococcus hirae. J Bacteriol 188: 6298-647 
6307. 648 
56. Yoshida H, Kawai F, Obayashi E, Akashi S, Roper DI, et al. (2012) Crystal Structures of 649 
Penicillin-Binding Protein 3 (PBP3) from Methicillin-Resistant Staphylococcus aureus 650 
in the Apo and Cefotaxime-Bound Forms. J Mol Biol 423: 351-364. 651 
57. Romeis T, Holtje JV (1994) Specific interaction of penicillin-binding proteins 3 and 7/8 652 
with soluble lytic transglycosylase in Escherichia coli. J Biol Chem 269: 21603-653 
21607. 654 
58. Jennings GT, Savino S, Marchetti E, Arico B, Kast T, et al. (2002) GNA33 from Neisseria 655 
meningitidis serogroup B encodes a membrane-bound lytic transglycosylase (MltA). 656 
Eur J Biochem 269: 3722-3731. 657 
59. Lovell SC, Davis IW, Arendall WB, 3rd, de Bakker PI, Word JM, et al. (2003) Structure 658 











  669 
  670 
 28 
 671 
Table 1: Data collection and refinement statistics 672 
Crystal PBP357-577 PBP388-165 
SeMet derivative 
PBP388-165 
PDB code 4BJP  4BJQ 
Data Collection:    
Space group P6122 P1 P1 
Cell Dimensions    
a, b, c (Å) 119.0, 119.0, 139.2 55.8, 55.8, 81.5 56.0, 56.0, 82.3 
α, β, γ (°) 90, 90, 120 75.8, 89.4, 65.3 76.2, 89.1, 66.0 
Resolution range (Å)
a
 82.8 – 2.5 (2.64 – 
2.5) 
49 – 2.7 (2.85-
2.70) 
38.9 - 2.10 
(2.21 – 2.10) 
No. of unique reflections 20753 45763 45669 
Rmerge (%)
a 
16.6 (54.3) 11.7 (47.8) 8.0 (50.8) 
<I>/<σI> a 13.5 (4.9) 8.7 (2.6) 10.2 (2.5) 
Completeness (%)
a
 99.8 (98.8) 95.4 (93.8) 88.5 (95.4) 
Redundancy
 a
 14.0 (10.4) 2.6 (2.6) 3.7 (3.8) 
Refinement:    
Resolution range (Å) 59.5 - 2.5  35.7 – 2.1 
No. of non hydrogen atoms 3409  5467 
Number of water molecules 135  533 
R cryst (%) 19.9  20.8 




Statistics for the highest resolution shell are given in parentheses. 674 
b




RMS deviations from ideal 
Stereochemistry 
   
Bond lengths (Å) 0.012  0.010 
Bond angles (
o
)  1.41  1.19 




34.1  31.9 
Ramachandran plot 
b
    
 Favoured region (%)   98.5  99.7 
 Allowed regions (%)  1.5  0.3 
 Outlier regions (%)  0  0 
Dear Editors, 
We have tried to address the concerns of reviewer 1 about the structure. Typographical errors 
found mainly by reviewer 2 have been corrected and the paper was read by an English native 
speaker. Finally, as suggested by reviewer 3, we have expanded the description of the structure 
and modified the figures accordingly. Details follow. 
 
Reviewer #1 
1. lines 125-129 … The authors state that PBP3(57-577) crystalization “could not be reproduced 
despite countless attempts.” First, surely there were not “countless” attempts. About how 
many attempts were made, and do the authors have any ideas about what the problem 
might be? This is rather important since it is unlikely that the work can be replicated by 
others if it cannot be replicated here. Second, with only one successful crystallization, how 
confident are the authors about the nature of the results? 
R: The apparent very narrow range of crystallization conditions resulted in only some very 
small badly diffracting crystals and one crystal diffracting at 2.5 Å. This sentence was added 
to the manuscript.  
In the case of several PBPs structures, the difficulties encountered in obtaining high 
resolution x-ray data sets, in reproducing crystals or even obtaining crystals, are mainly 
due to their nature of multi-domain proteins, for which several relative conformations of 
the different domains co-exist in solution. That’s why multi-domain protein structures are 
frequently determined from a single X-ray dataset but this has no impact on the soundness 
of structure determination. 
 
2. lines 212-213 … The PBP3 structure was evidently not determined de novo, but by 
comparison with the structure of PBP2 from a different organism, N. gonorrhoeae. This, 
when combined with the fact that only one crystallization attempt was successful, makes me 
wonder if this is the real structure of PBP3 or if it is only a single possible structure that can 
be made to conform to the structure of a somewhat distant homologue. Why can the 
structure not be generated on its own, and what are the limitations imposed by the modeling 
method?  
R: Structure determination by molecular replacement using the structure of a homologous 
protein (NgPBP2) is also a standard method that does not impact the confidence that the 
structure determined corresponds to the protein that has been crystallized. R and Rfree 
values are good criteria to ensure that the structure corresponds to the X-ray measures, 
independently of the initial structure used for molecular replacement.   
Efforts have been made to clearly show in figure 1 the part of the structure that was 
determined from X-ray data and the modeled parts of the structure.  
 
 
3. lines 378-380 … The authors could not reproduce interactions between the PBP3(88-165) 
fragment and other cell division proteins. If these interactions do not occur, doesn’t this call 
into question the biological relevance of the structure obtained for this fragment? 
Response to Reviewers
R: No. The structure of the domain 88-165 compares well with the equivalent domains of 
other class B-PBPs. The biological relevance of the swapping associated with the structure 
of the domain alone is indeed questionable but we think that the discussion states it 
clearly. 
 
4. In Figure S3, very little of the PBP3(57-577) seems to have co-precipitated with the 
peptidoglycan preparation. Why? The authors should quantify how much was precipitated 
and compare it to what might be expected. 
 
R: A similar test was done with LpoA-LpoB (Typas et al, Cell. 2010, 143:1097) without 
quantification, which is difficult. Clearly, only a fraction of the protein was precipitated. A 
possible explanation is that PBP3 interacts only with the septal peptidoglycan, which 




5. line 69 … should be “LpoB” (capital “B”) 
Done 
 









1. l. 47: it is not clear what is meant by "direct" peptidoglycan synthesis. Is there something 
like indirect synthesis? 
“Direct” has been removed 
 
2. l. 69: should be "LpoB" with capital "B" 
Done 
 
3. l. 96: the 2XYT medium should be defined. 
Done 
 
4. l. 98: should be "0.5 mM" 
Done 
 
5. l. 113/117/119: what is meant with "ch/h" and "cm/h". Flow rates should be given in 
"ml/min" or "ml/h". 
R: Typing error, ch/h doesn’t exist,  it’s cm/h (linear flow rate, which is independent of the 
diameter of the column, instead of the flow rate in ml/h  which is dependent of the column 
diameter). The linear flow rate is preferred by people making a scale-up because it’s the 
real value independent of the column size allowing to compare different size of columns; 
for example 100 mL/h used for two columns having a surface doubling will make a factor 
two for the residence time. 
Linear flow rate (cm/h) X surface (cm2) = volumetric flow rate (ml/h) 
In our case with the XK50 column (diameter = 5 cm surface = 19.63 cm2 
31 cm/h = 608 mL/h; 15 cm/h = 294 mL/h 
 
 
6. l. 122: it is not clear what is meant by "three-dimensional environment with 30% of alpha-
helix". Please re-phrase to make the sentence clear. 
R: The sentence was changed. 
 
 
7. l. 127: "CAPS" needs to be defined. 
Done 
 
8. l. 197-202. "KDa" should be corrected to "kDa".  
Done; also in figure legends. 
 
9. l. 213: missing blank. 
Added 
 
10. l. 229: define "mDAP" 
Done 
 
11. l. 264-264: What is meant by "...and the conformation of the segment 402-420 are 
conserved in all PBPs."? What is meant here with "conformation"? Also, you need to clarify if 
the "conformation" is conserved in all known PBP structures, or in all class B PBPs, or what is 
meant here. 
R: The sentence was modified 
 
12. l. 284. Here, it does not become clear why the comparison with other PBPs provides 
evidence for flexible junction between the modules. What is the evidence, and how has it 
been obtained? Also, have other computational methods been used to assess the flexibility? 
R: Evidence is suggested also by apo and acyl structures of PBP3 from Pseudomonas 
aeruginosa (Sainsbury, JMB, 405, 173-184). The flexibility of the junction also exists in class 
A PBPs. We have modified the sentence, added a figure as suggested by reviewer 3 remark 
9, and added references. 
 
13. l. 287: what is meant with "processive displacement of the divisome"? 
R: It means divisome displacement during processive glycan chain synthesis. The sentence 
has been simplified 
 14. l. 298: should be "Marrec-Farley" with capitol "F".  
OK (Marrec-Fairley) 
 
15. l. 425. It must be clearly stated in the heading of the legend and in part (a) that the figure 
shows a model of the PBP3 structure, and not the crystal structure itself (as is written).  
R: The figure was modified according to reviewer3’s suggestion showing now the crystal 
structure in cartoon and a light trace of the modelled loops. 
 
16. l. 431. should be "Tyr".  
OK 
 
17. Figure 1: should it be "Loop 202-228" (instead of "Loop 220-228") to be consistent with 
the text? 
R: The correction was done in figure 1 
 
 
Reviewer #3:  
1. Analysis of Figure 1 gives the reader the impression that the structure includes the transmembrane 
region, as well as the full N-terminal domain. Reading of the figure legend, however, indicates that 
the TM was modeled, and so were all of the regions in cyan. Since this is a very important figure for 
the paper, and could be eventually used by other scientists for teaching, etc, it should only include 
the regions that could be traced in a trustworthy fashion in the map. The TM region does not have to 
be included (it is not helpful for the figure, or even mentioned in the text), and all loops and regions 
that were modeled should be replaced by dots.  
R: The figure has been modified as suggested by the reviewer. The modeled loops are now shown 
in very light grey and the TM helix has been removed. We have also followed the reviewer’s 
remark 15 suggesting showing beta-strands colored differently from alpha-helices. 
 
2. It is unclear to the reader why authors started their clone at residue 57; a schematic figure could 
be included, describing the exact construct that was used and the structure that was traced. 
R: The construct starting at residue 57 was less prone to degradation that a construct starting at 
residue 37. See Fraipont C et al. (1994) Engineering and overexpression of periplasmic forms of the 
penicillin-binding protein 3 of Escherichia coli. Biochem J 298 ( Pt 1): 189-195. The reference has 
been added in the material and method section. 
Figure 1 now clearly shows the construct and the difference between what was seen in the map 
and the modeled loops. 
 
3. P. 10, lines 220-221, it is rather strange to mention that the C-terminus is associated to the N-
terminus; do authors mean to say that it interacts closely? 
R: The sentence has been made clearer. 
 
4. Although one has the impression that there are 4 individual figures, in fact they are only 2, parts A 
and B of the same figure having been separated into different files. As a consequence, this 
manuscript only has 2 figures. Authors could illustrate their manuscript better by adding additional 
figures; for example, showing the ‘long groove’ that is alluded to on p. 10, lines 227-228. 
R: We have added some figures: a model with part of the substrate showing the long groove 
(remark 5) and a figure showing the superposition of different class B-PBPs (remark 9). We have 
included the supplementary figures in the manuscript. 
Figure 1: structure of PBP3 
Figure 2: Active site 
Figure 3: Junction 
Figure 4: Domain 88-165 
Figure 5 : PBP3 oligomerization 
Figure 6 : Interaction with peptidoglycan 
5. There is a paper from the Mobashery lab describing the structure of an E. coli PBP (5/6) with a 
peptide in the active site; since authors mention that their long groove could bind substrate, how 
does it compare to this paper? Is it possible to model a peptide in their structure? 
R: We have modeled the acyl-enzyme with D-Glu-mDap-D-Ala linked to the active serine and made 
a figure of it. The model is based on an unpublished acyl-enzyme structure that we have obtained 
with another PBP (the DD-peptidase from Actinomadura R39) rather than the Mobashery’s one, 
which has a lysine instead of diaminopimelic acid in the peptide 
 
6. P.10, after lines 223-224, a reference should be cited. 
R: As lines 223-224 are empty, we believe that reviewer’s remark relates to lines 233-234, where 
we have added a reference. 
 
7. P.12, this part of the text refers to figure 1b, which is rather problematic. Details about a pocket 
are described, but by looking at the figure one does not have the impression to see a pocket; since 
one of the beta-strands was shown as sticks (which is not really helpful), it gives the reader the 
impression that there is a peptide bound to the active site. In order to make this clearer, authors 
should show the active site with arrows for beta strands (that should be labeled as per other PBPs … 
the beta-strands neighboring the active site on this figure are beta3 and beta4). 
R: There are now two figures showing the active site. The first (figure 2a) shows the groove (cf 
remark 5) and the second is the former figure 1b (now 2b) modified as suggested by the reviewer 
(strand beta3 shown as a strand and labeled). Both are in stereo (cf remark 13)  
 8. P.12, lines 269-270: please mention the nomenclature for the beta strands involved, and add 
references here.  
R: Nomenclature and references have been added 
 
9. P.12, lines 283-284: these interesting sentences could be illustrated by a figure highlighting the 
differences between junctions for different PBPs (and references should also be added) 
R: Details were added to the text and a new figure illustrates these sentences (figure 3). 
10. 9. P. 14, line 310, please replace ‘tridimensional’ by ‘three-dimensional’ 
Done  
 
11. If authors only have 2 figures in their manuscript, why did they include three supplementary 
figures? All of the data can be included in the main text. 
We have integrated all the figures in the manuscript 
 
12. It is curious that on p. 16 lines 374-375 authors discuss the fact that a role for domain swapping 
in the in vivo dimerization process of PBP3 is elusive, and in lines 380-381 go on to discuss that their 
could be a role for this in vivo. 
R: In lines 380-381, we mention the possible influence of the in vitro dimerization of domain 88-
165 on the result of interaction tests. We have slightly modified the sentence to avoid confusion 
 
13. Figure 1, legend: this reviewer recommends that secondary strand elements be labeled, as 
suggested above. What do authors mean by ‘unhide’ Tyr514? If their objective is to show it clearly, 
they could potentially change the angle, or make a stereo figure, or make a LigPlot figure ... 
R: See remark 7 
 
14. I’m not quite sure how relevant Fig. 2b is, especially considering that authors clearly mention that 
these interactions are probably not relevant in the full-length PBP3 structure. They could potentially 
replace it by supplementary data, or other images of the full-length crystal structure. What does a 
surface charge diagram look like?  
R: We have kept this illustration, which makes the description of the swapping easier to 
understand.  
15. These authors published a beautiful review article in FEMS a few years ago where they showed 
the transpeptidase domain of PBPs with beta-strands colored differently from alpha-helices; they 
could perhaps adopt that strategy for this paper, and modify Figs. 1a/1b accordingly. 
R: We have modified figure 1 as suggested 
  
